Selective serotonin reuptake inhibitors

SSRI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AB 1 out of 7 registries used, show all original rules.	111120
4. Check minimum number of events Min. number of events 3	111120
5. Include endpoints None	111120
6. Filter based on genotype QC (FinnGen only)	107180

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SSRI
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AB
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Selective serotonin reuptake inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	107180	73463	33717
Unadjusted period prevalence (%)	22.72	26.06	15.45
Median age at first event (years)	41.35	39.29	45.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67998: Matched controls
354912

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SFA30

NOMESCO Finland

Three-surface restoration

1.4

322.6

23269

95763

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.3

321.3

858

855

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

320.5

5438

15916

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

13.5

320.3

456

177

T90

ICPC

Diabetes non-insulin dependent

1.5

320.0

11823

42651

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

319.8

15201

57841

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.2

318.5

733

619

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

318.3

12997

47913

J01MA02

ATC

ciprofloxacin; systemic

1.4

316.9

21209

86065

309

Kela drug reimbursment

Nalmefene and naltrexone

25.5

316.5

364

N06BA12

ATC

lisdexamfetamine; oral

7.7

316.2

621

427

F61

ICD-10 Finland

Mixed and other personality disorders

22.0

316.2

378

SPAT1260

SPAT

Consultation of another employee

1.6

315.5

9413

32289

J01FA06

ATC

roxithromycin; oral

1.4

315.2

21677

88369

M79.1

ICD-10 Finland

Myalgia

1.7

314.6

7553

24494

OAB93, ,

SPAT

2.3

314.5

3040

7197

Z08

ICPC

Social welfare problem

5.8

314.4

768

695

P80

ICPC

Personality disorder

26.8

314.3

357

IEV99

NOMESCO Finland

Other psychiatric network intervention

14.6

313.9

433

156

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

313.0

7879

25876

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

312.6

2594

5728

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

311.8

2384

5058

M01AC06

ATC

meloxicam; systemic, rectal

1.4

311.5

18616

73957

F60.7

ICD-10 Finland

Dependent personality disorder

43.3

311.4

322

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

310.2

10459

36924

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

26.5

309.9

353

P02

ICPC

Acute stress reaction

2.3

309.8

2861

6637

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.8

307.8

1185

1639

N03AF01

ATC

carbamazepine; oral, rectal

3.0

307.7

2898

5229

L03

ICPC

Low back symptom/complaint

1.7

307.7

16020

53320

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

307.7

9503

30213

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

34.2

307.7

783

121

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.4

307.7

1976

1438

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

16204

54162

N03AE01

ATC

clonazepam; systemic

6.9

307.7

4645

3723

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

18.0

307.7

833

245

N06AB08

ATC

fluvoxamine; oral

44.6

307.7

3014

369

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

32.6

307.7

1869

307

N06AA22, ,

ATC

37.4

307.7

470

L01

ICPC

Neck symptom/complaint

1.7

307.7

8335

26338

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

11.3

307.7

644

299

N03AX16

ATC

[U] pregabalin

2.7

307.7

15087

34007

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

129.0

307.7

5833

258

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

7.6

307.7

2842

2020

P28

ICPC

Limited function/disability (P)

9.0

307.7

595

349

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.0

307.7

874

768

F41.1

ICD-10 Finland

Generalized anxiety disorder

12.7

307.7

5554

2461

P19

ICPC

Drug abuse

7.4

307.7

671

475

F34.1

ICD-10 Finland

Dysthymia

42.2

307.7

4090

537

N06AX26

ATC

vortioxetine; oral

50.7

307.7

7887

917

N05AN01

ATC

lithium; oral

17.1

307.7

2312

730

P06

ICPC

Sleep disturbance

3.2

307.7

8283

14833

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

307.7

3103

7134

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.5

307.7

3309

2116

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

307.7

13491

48572

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

39.1

307.7

1637

224

L28

ICPC

Limited function/disability (L)

1.9

307.7

9100

26697

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

307.7

12053

43413

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

17281

63754

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

307.7

3434

7242

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

19.1

307.7

583

161

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

23715

90521

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

23.3

307.7

522

118

J01AA02

ATC

doxycycline; systemic

1.5

307.7

46364

209501

V03AA01, ,

ATC

9.9

307.7

1306

703

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.0

307.7

880

666

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

14.7

307.7

696

249

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.0

307.7

862

508

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

51.2

307.7

1318

137

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

45.9

307.7

2747

325

IGV01

NOMESCO Finland

Psychiatric network contact

14.8

307.7

774

276

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

25.6

307.7

2754

585

P74

ICPC

Anxiety disorder/anxiety state

11.6

307.7

4259

2040

P16

ICPC

Acute alcohol abuse

7.6

307.7

1250

872

R06.5

ICD-10 Finland

Mouth breathing

1.9

307.7

4900

13615

N06AX21

ATC

duloxetine; oral

15.4

307.7

10651

4236

R74

ICPC

Upper respiratory infection acute

1.5

307.7

18671

72648

N05AH04

ATC

quetiapine; oral

13.6

307.7

21338

11576

N06AX12

ATC

bupropion; oral

44.1

307.7

8560

1156

V03AB30, ,

ATC

12.3

307.7

529

227

F60.8

ICD-10 Finland

Other specific personality disorders

21.0

307.7

520

130

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.2

307.7

1226

1537

N06AB06

ATC

sertraline; oral

44.3

307.7

17511

2756

IBA03

NOMESCO Finland

Psychotherapy evaluation

12.9

307.7

671

273

SPAT1216

SPAT

Assessment of functional ability

1.8

307.7

7665

23752

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

307.7

5018

13730

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

307.7

41011

182996

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

32.6

307.7

447

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.8

307.7

1334

1477

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

307.7

15283

53645

J01DA01

ATC

[U] cefalexin

1.5

307.7

37317

160539

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

16.3

307.7

542

175

F41.3

ICD-10 Finland

Other mixed anxiety disorders

9.7

307.7

1200

653

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.3

307.7

3186

4006

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.1

307.7

1462

1516

N05AH03

ATC

olanzapine; systemic

12.8

307.7

6871

3082

F32.1

ICD-10 Finland

Moderate depressive episode

14.8

307.7

6198

2386

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

25.4

307.7

1205

252

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.9

307.7

1031

793

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.4

307.7

1407

1163

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.3

307.7

642

408

P76

ICPC

Depressive disorder

23.2

307.7

7742

1956

N05AC02

ATC

thioridazine; oral

5.9

307.7

1340

1206

N05CF01

ATC

zopiclone; oral

4.5

307.7

26821

44851

IGY02

NOMESCO Finland

Psychiatric monitoring contact

12.5

307.7

2558

1110

F32.9

ICD-10 Finland

Depressive episode, unspecified

19.5

307.7

16675

5824

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

70.9

307.7

7007

574

SPAT1254

SPAT

Administration of medicine

1.8

307.7

8514

25549

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.1

307.7

6078

5619

N05AB03

ATC

perphenazine; systemic, rectal

13.6

307.7

3328

1341

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

307.7

24751

97607

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

24275

84779

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

21.9

307.7

612

147

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.7

307.7

3465

5120

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

9.1

307.7

11036

7390

F39

ICD-10 Finland

Unspecified mood [affective] disorder

11.5

307.7

1570

729

N03AG01

ATC

valproic acid; systemic, rectal

6.6

307.7

5330

4505

P25

ICPC

Phase of life problem adult

3.3

307.7

2642

4296

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.7

307.7

980

596

A02BC03

ATC

lansoprazole; oral

1.8

307.7

16550

53167

C07AA05

ATC

propranolol; systemic

3.7

307.7

16733

28524

IHZ04, ,

SPAT

8.4

307.7

815

512

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.4

307.7

2394

1376

N06AB03

ATC

fluoxetine; oral

33.9

307.7

18136

3763

SPAT1240

SPAT

Therapeutic discussion

5.6

307.7

10051

10668

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

307.7

3463

7418

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

16536

54386

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

44505

194413

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

12650

42008

EBA00

NOMESCO Finland

Extraction of tooth

1.5

307.7

21206

82211

N06AX22

ATC

agomelatine; oral

78.6

307.7

2160

148

D11

ICPC

Diarrhoea

1.9

307.7

6806

19713

Z71.8

ICD-10 Finland

Other specified counselling

1.6

307.7

18054

65496

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

307.7

3430

7307

R53

ICD-10 Finland

Malaise and fatigue

2.4

307.7

16661

41601

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

47.4

307.7

442

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

15.0

307.7

637

223

R42

ICD-10 Finland

Dizziness and giddiness

1.8

307.7

12997

40670

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

35.7

307.7

354

SPAT1234

SPAT

Support of social functional capacity

3.2

307.7

2892

4899

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

12782

40798

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

307.7

4804

11182

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

307.7

6121

16447

IGY02, ,

SPAT

12.0

307.7

908

400

N07BB01

ATC

disulfiram; oral

11.1

307.7

4510

2257

G47.3

ICD-10 Finland

Sleep apnoea

2.2

307.7

14534

39129

N06AA12

ATC

doxepin; systemic

17.0

307.7

4550

1494

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.1

307.7

9112

8723

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.6

307.7

1753

2013

F41.00

ICD-10 Finland

Moderate panic disorder

24.7

307.7

1515

327

SPAT1238

SPAT

Brief therapy

5.8

307.7

1206

1104

N06AX03

ATC

mianserin; oral

28.5

307.7

4777

940

KMAK, ,

NOMESCO Finland

1.4

307.7

29912

128040

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

307.7

5480

11476

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.4

307.7

1447

743

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

75.3

307.7

430

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

22.1

307.7

537

128

R51.80

ICD-10 Finland

Headache

2.1

307.7

9513

25621

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

39.6

307.7

907

121

F31

ICD-10 Finland

Bipolar affective disorder

21.0

307.7

1084

274

ZY000

NOMESCO Finland

Hospital inpatient

9.7

307.7

1004

547

N01

ICPC

Headache

1.9

307.7

6655

19144

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

8.0

307.7

698

462

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

307.7

4206

10272

Z72.1

ICD-10 Finland

Alcohol use

6.0

307.7

866

762

N05AD03

ATC

melperone; systemic

7.3

307.7

935

681

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

25627

90582

M79.7

ICD-10 Finland

Fibromyalgia

5.6

307.7

1963

1889

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.2

307.7

2652

2768

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

40.1

307.7

549

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

21302

74826

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

18.3

307.7

1729

504

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

307.7

4991

12225

N03AX12

ATC

[U] gabapentin; oral

2.6

307.7

9706

21634

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

307.7

3185

5953

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.7

307.7

2456

1962

N06AX05

ATC

trazodone; oral

50.1

307.7

2311

249

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

33957

133347

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

25.9

307.7

848

173

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

21.8

307.7

10395

2912

N05BA05

ATC

potassium clorazepate; oral

12.4

307.7

610

259

IER01

NOMESCO Finland

Psychoeducation, group

15.8

307.7

516

172

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

307.7

2268

4223

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

307.7

3324

7912

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

14.9

307.7

2415

873

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

12.7

307.7

649

269

F41.01

ICD-10 Finland

Severe panic disorder

39.0

307.7

512

S06.0

ICD-10 Finland

Concussion

2.0

307.7

6367

17201

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

307.7

15333

52348

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.0

307.7

1807

2408

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

8205

22746

N05AE04

ATC

ziprasidone; systemic

25.1

307.7

510

107

UJF32

NOMESCO Finland

Coloscopy

1.5

307.7

13363

49352

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.9

307.7

4208

5961

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

24335

93578

G04BD12

ATC

mirabegron; oral

1.9

307.7

5493

15790

N05BA01

ATC

diazepam; systemic, rectal

5.8

307.7

12111

12693

SPAT1263

SPAT

Sampling

1.4

307.7

24016

98697

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

19164

75094

N05BA06

ATC

lorazepam; systemic, sublingual

7.9

307.7

4527

3194

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

307.7

10858

35122

Z3226

NOMESCO Finland

Physiotherapist

1.8

307.7

9928

31507

N05CF02

ATC

zolpidem; oral

4.4

307.7

13882

19763

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

307.7

25075

99884

N05AD01

ATC

haloperidol; systemic

4.6

307.7

2130

2487

A28

ICPC

Limited function/disability NOS

1.8

307.7

8136

24815

F32.8

ICD-10 Finland

Other depressive episodes

16.4

307.7

1344

435

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

27.0

307.7

707

138

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

17689

65548

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

11.7

307.7

1385

632

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

36294

154750

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.7

307.7

2807

2680

N05AB01

ATC

dixyrazine; systemic

14.0

307.7

993

374

N05AX08

ATC

risperidone; systemic

7.2

307.7

7887

6316

P20

ICPC

Memory disturbance

1.9

307.7

6171

17353

AA400

NOMESCO Finland

Electroconvulsive therapy

62.7

307.7

749

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

43.6

307.7

2365

293

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

28571

116121

M25.5

ICD-10 Finland

Pain in joint

1.5

307.7

17171

65991

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

307.7

13028

45465

P01

ICPC

Feeling anxious/nervous/tense

5.4

307.7

11793

13250

F22.0

ICD-10 Finland

Delusional disorder

5.8

307.7

891

806

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

13.6

307.7

1360

532

188

Kela drug reimbursment

Psychosis requiring demanding treatment

11.9

307.7

735

326

H02AB06

ATC

prednisolone; systemic

1.4

307.7

26595

110633

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.5

307.7

10085

7103

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

307.7

5165

12619

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

61.9

307.7

5120

466

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

307.7

7676

23873

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

307.7

6317

18992

SFA20

NOMESCO Finland

Two-surface restoration

1.4

307.7

34648

151125

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

18.5

307.7

1180

338

J01CA04

ATC

amoxicillin; systemic

1.4

307.7

51381

241773

N02BE01

ATC

paracetamol; systemic, rectal

1.9

307.7

56820

258363

A02BA02

ATC

ranitidine; systemic

1.9

307.7

10734

31262

R01AD09

ATC

mometasone; nasal

1.5

307.7

26602

107238

N06AA09

ATC

amitriptyline; systemic

7.0

307.7

6875

5629

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

15549

57419

R52.2

ICD-10 Finland

Other chronic pain

3.3

307.7

1844

3003

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

17.9

307.7

498

146

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

307.7

2914

5584

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.6

307.7

2642

5424

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

17610

61915

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

307.7

3441

7428

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.6

307.7

740

588

R06.0

ICD-10 Finland

Dyspnoea

1.8

307.7

15152

49139

E0000UV, ,

ATC

1.4

307.7

23825

97206

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

307.7

4872

10917

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

19.6

307.7

2617

725

F40.1

ICD-10 Finland

Social phobias

19.5

307.7

2709

755

N06AB05

ATC

paroxetine; oral

38.4

307.7

7943

1219

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

19.6

307.7

894

241

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

9736

30690

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.7

307.7

1082

1225

F32

ICD-10 Finland

Depressive episode

17.7

307.7

6040

1942

N06AX11

ATC

mirtazapine; oral

10.8

307.7

33699

29683

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

26.8

307.7

408

A10BA02

ATC

metformin; oral

1.5

307.7

14715

54394

A04

ICPC

Weakness/tiredness general

2.2

307.7

9404

23665

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

45087

197522

N05AA01

ATC

chlorpromazine; systemic, rectal

9.4

307.7

958

540

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

26023

98677

N05AF01

ATC

flupentixol; systemic

19.8

307.7

1316

353

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

22912

78732

SPAT1243

SPAT

Psychiatric/psychological examination

7.6

307.7

2266

1604

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

307.7

15592

44003

P99

ICPC

Psychological disorders other

10.6

307.7

2627

1336

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

11.6

307.7

867

394

N03AX11

ATC

topiramate; oral

5.0

307.7

1472

1571

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

52.0

307.7

495

A06AD11

ATC

lactulose; oral

2.4

307.7

8752

20956

IGY99

NOMESCO Finland

Other psychiatric treatment contact

15.1

307.7

1819

643

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

40.2

307.7

8229

1212

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

34294

142234

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

16.9

307.7

3343

1085

F60.5

ICD-10 Finland

Anankastic personality disorder

18.5

307.7

891

255

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.7

307.7

1400

588

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

24.3

307.7

514

111

N05BE01

ATC

buspirone; oral

32.3

307.7

3249

551

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.6

307.7

1053

734

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

307.7

6472

18996

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

307.7

6768

19717

AA1AD

NOMESCO Finland

CT of head and brain

1.9

307.7

15310

47959

N05BA12

ATC

alprazolam; oral

10.9

307.7

10748

6023

N05BA02

ATC

chlordiazepoxide; systemic

13.0

307.7

2125

880

N04BC05

ATC

pramipexole; oral

2.6

307.7

3982

8303

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

50.7

307.7

338

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

22713

86894

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

50.2

307.7

392

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

307.7

7348

22209

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

13.6

307.7

480

185

P27

ICPC

Fear of mental disorder

6.8

307.7

840

652

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.1

307.7

7789

8741

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

13.3

307.7

1709

687

N05AH02

ATC

clozapine; systemic

10.3

307.7

1632

844

F50.2

ICD-10 Finland

Bulimia nervosa

15.7

307.7

450

151

F41.09

ICD-10 Finland

UNS Panic Syndrome

13.8

307.7

2892

1141

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

307.7

3044

6278

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

307.7

10539

33000

N06AA04

ATC

clomipramine; systemic

37.5

307.7

1512

215

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

307.7

11471

39870

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.2

307.7

877

414

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.9

307.7

1935

2675

SFA10

NOMESCO Finland

One-surface restoration

1.4

307.7

32993

140155

F10.20

ICD-10 Finland

Alcohol dependence currently independent

16.0

307.7

1948

655

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

16.2

307.7

647

210

F21

ICD-10 Finland

Schizotypal disorder

13.7

307.7

458

175

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

9.4

307.7

647

361

N06AX17

ATC

milnacipran; oral

87.5

307.7

894

E66.8

ICD-10 Finland

Other obesity

2.7

307.7

3230

6332

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

14.7

307.7

475

170

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

12.1

307.7

4109

1880

T36

ICD-10 Finland

Poisoning by systemic antibiotics

13.6

307.7

4371

1785

IEY01

NOMESCO Finland

Psychoeducation, individual

14.3

307.7

588

217

A01

ICPC

Pain general/multiple sites

2.3

307.7

4887

11696

SPAT1235

SPAT

Mental health, emotional support

11.4

307.7

539

249

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

13698

49726

F10.24

ICD-10 Finland

Alcohol depence active use

13.1

307.7

1286

521

N06AG02

ATC

moclobemide; oral

30.2

307.7

4383

807

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

307.7

4998

13942

T82

ICPC

Obesity

2.8

307.7

2261

4262

N06AB10

ATC

escitalopram; oral

42.8

307.7

33829

8022

F31.8

ICD-10 Finland

Other bipolar affective disorders

23.1

307.7

1750

406

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

307.7

3394

7374

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

7.3

307.7

1482

1079

N05AA02

ATC

levomepromazine; systemic

14.2

307.7

4096

1594

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

16.0

307.7

2050

690

N06AX18

ATC

reboxetine; oral

71.4

307.7

1024

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

7876

21416

N05AL01

ATC

sulpiride; systemic

22.3

307.7

1270

303

N06AA10

ATC

nortriptyline; systemic

7.4

307.7

1143

822

SPAT1301

SPAT

No procedures

1.5

307.7

17465

66187

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

33216

137806

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

307.7

20551

77105

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

24.2

307.7

501

109

P15

ICPC

Chronic alcohol abuse

7.8

307.7

2491

1717

N03AX09

ATC

lamotrigine; oral

14.8

307.7

4907

1855

F33

ICD-10 Finland

Recurrent depressive disorder

51.7

307.7

2215

231

P18

ICPC

Medication abuse

15.9

307.7

473

156

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

14.4

307.7

707

258

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

307.7

31032

132218

Z2446

NOMESCO Finland

Social worker

3.3

307.7

4451

7302

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

54.6

307.7

550

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

13.5

307.7

1228

484

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

307.7

15733

52794

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

307.7

22364

90429

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

307.7

12300

43516

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.1

307.7

1036

675

F32.0

ICD-10 Finland

Mild depressive episode

7.6

307.7

2218

1566

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

43.6

307.7

2060

254

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

14.8

307.7

2688

982

P72

ICPC

Schizophrenia

7.8

307.7

1386

945

C07AB07

ATC

bisoprolol; oral

1.6

307.7

26612

102302

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

307.7

11910

42205

N06BA04

ATC

methylphenidate; oral

6.2

307.7

2569

2245

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

307.7

7745

15310

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

28209

113687

F99

ICD-10 Finland

Mental disorder, not otherwise specified

9.3

307.7

1685

965

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

14179

42267

P58

ICPC

Psychological, Therapeutic counselling/listening

4.7

307.7

1273

1431

SPAT1307

SPAT

Psychosocial counselling and guidance

4.4

307.7

5194

6612

IHZ05, ,

SPAT

5.0

307.7

2954

3189

N04AA02

ATC

biperiden; systemic

8.6

307.7

1469

910

F61.0

ICD-10 Finland

Mixed personality disorders

36.4

307.7

1706

251

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

17.6

307.7

1374

415

A03FA02

ATC

cisapride; oral, rectal

2.2

307.7

3956

9882

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

14.6

307.7

2995

1118

N05CD08

ATC

midazolam; nasal, systemic

3.9

307.7

1224

1645

F51.0

ICD-10 Finland

Nonorganic insomnia

3.9

307.7

12082

18531

F50.9

ICD-10 Finland

Eating disorder, unspecified

8.6

307.7

711

435

R11

ICD-10 Finland

Nausea and vomiting

2.2

307.7

4870

12168

Z2445

NOMESCO Finland

Psychologist

5.1

307.7

3053

3241

F51

ICD-10 Finland

Nonorganic sleep disorders

3.1

307.7

2358

4052

N05CD02

ATC

nitrazepam; oral

6.4

307.7

1033

859

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

12.3

307.7

2232

980

SPAT1310

SPAT

Counselling related to known health issue

1.5

307.7

17763

68697

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

39041

169453

N02BF01

ATC

gabapentin; oral

2.4

307.7

4161

9309

N05CD07

ATC

temazepam; oral

6.2

307.7

10305

9960

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.1

307.7

1709

699

P03

ICPC

Feeling depressed

9.2

307.7

10791

7151

F60.9

ICD-10 Finland

Personality disorder, unspecified

25.0

307.7

1185

252

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

57.5

307.7

1382

128

N06AB04

ATC

citalopram; systemic

41.8

307.7

33665

8133

N06AA06

ATC

trimipramine; systemic

24.1

307.7

2003

447

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

307.7

8759

26462

Z2221

NOMESCO Finland

Medical doctor

1.6

307.7

15425

56244

J01CA08

ATC

pivmecillinam; oral

1.4

307.7

21025

84753

F33.8

ICD-10 Finland

Other recurrent depressive disorders

57.5

307.7

784

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.9

307.7

2279

1028

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

307.7

8382

26649

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

6520

19774

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

11.3

307.7

7935

4086

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

146.6

307.7

1024

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

89.0

307.7

2308

140

R06AE07

ATC

cetirizine; oral

1.5

307.7

26133

103362

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

307.7

7456

21934

N02BF02

ATC

pregabalin; oral

3.6

307.7

3516

5347

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

42572

165784

F41

ICD-10 Finland

Other anxiety disorders

6.7

307.7

1218

960

ZY010

NOMESCO Finland

Hospital outpatient

5.3

307.7

4216

4347

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

21.6

307.7

1306

321

J02AC01

ATC

fluconazole; systemic

1.5

307.7

21821

83317

A02BC01

ATC

omeprazole; systemic

1.8

307.7

16375

52064

R02

ICPC

Shortness of breath/dyspnoea

1.9

307.7

7016

20428

N06AX16

ATC

venlafaxine; oral

42.1

307.7

17162

2822

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

307.7

10252

34347

J01DB01

ATC

cefalexin; oral

1.6

307.7

52351

240559

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

44.1

307.7

3295

409

M03BX02

ATC

tizanidine; oral

1.7

307.7

37804

152940

K59.0

ICD-10 Finland

Constipation

2.3

307.7

2978

6845

N05BA04

ATC

oxazepam; oral

8.6

307.7

27867

26570

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.7

307.7

1612

1112

N05AX12

ATC

aripiprazole; systemic

19.0

307.7

4553

1333

P29

ICPC

Psychological sympt/compl other

5.8

307.7

6338

6185

N02AA05

ATC

oxycodone; systemic

1.7

307.7

8506

26887

N05AF03

ATC

chlorprothixene; systemic

19.0

307.7

2597

739

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

307.7

3061

6094

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

307.2

14117

53283

Z73.0

ICD-10 Finland

Burn-out

2.7

306.6

2031

3998

SPAT1265

SPAT

Breathalyser

7.1

306.5

634

468

ZXE00

NOMESCO Finland

One hour or less

1.4

305.8

21461

87680

M02AA07

ATC

piroxicam; topical

1.4

305.2

18517

73707

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

304.7

4628

13046

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

304.3

7245

23426

R01AD08

ATC

fluticasone; nasal

1.5

304.1

15674

60499

M01AH01

ATC

celecoxib; oral

1.6

302.5

8751

29763

L02

ICPC

Back symptom/complaint

1.8

302.1

5312

15712

SPAT1284

SPAT

Extensive health certificate

3.1

301.8

1608

2788

IHZ02, ,

SPAT

5.1

301.6

831

855

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3035350) Ketones [Presence] in Urine by Test strip

30067

129295

1.38

321.61

3.8

3.3

0.00

estimate

1.30

6245

25149

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

9505

32556

1.61

321.04

2.3

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10339

36263

1.58

315.92

2.4

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10606

37473

1.57

313.84

1.9

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

30002

129343

1.38

312.71

5.1

4.5

0.00

estimate

0.48

5998

24008

(3026782) Osmolality of Urine

13142

48740

1.50

312.01

3.0

2.8

529.51

556.81

mosm/kgh2o

31.33

11230

41961

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6860

21708

1.72

311.93

2.6

2.4

47.45

46.85

u/l

0.02

5824

18724

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14414

54612

1.48

307.87

1.8

1.08

1.24

mg/l

5.00

10687

41569

(3000850) Epithelial cells [#/volume] in Urine

13821

51243

1.51

307.65

2.7

2.5

6.08

5.29

e6/l

7.54

12309

45876

(3018010) Neutrophils/100 leukocytes in Blood

30835

124230

1.54

307.65

6.1

5.8

57.06

57.14

0.48

28790

117125

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

33351

127350

1.72

307.65

5.7

6.1

10.62

11.77

umol/l

46.20

31306

121037

(3011288) Drugs identified in Urine by Screen method

4030

5324

4.14

307.65

3.9

2.0

—

(3044889) 12 lead EKG panel

41353

177473

1.55

307.65

3.8

3.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

36635

148777

1.62

307.65

10.0

8.6

4.16

4.09

e9/l

6.58

31907

130109

(40758558) Short blood count panel - Blood

16576

63149

1.49

307.65

7.2

6.7

—

(40768797) Stomach Pathology biopsy report

9441

31567

1.65

307.65

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

59967

274673

2.18

307.65

17.6

13.9

139.53

139.69

mmol/l

44.71

58439

267226

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

61062

294190

1.82

307.65

11.2

9.1

27.88

26.52

u/l

20.76

58968

284058

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

27807

92945

1.95

307.65

2.1

1.8

97.24

95.45

pmol/l

6.92

14857

49260

(3022096) Basophils/100 leukocytes in Blood

29359

117201

1.54

307.65

6.3

6.0

0.67

0.30

27231

109782

(3000764) Benzodiazepines [Presence] in Urine

4853

10191

2.60

307.65

2.9

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

45687

191104

1.76

307.65

4.1

3.8

11.30

11.54

mm/h

2.82

42160

177561

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1268

680

9.90

307.65

17.8

21.3

2193.94

2393.13

nmol/l

0.06

1222

654

(3006315) Basophils [#/volume] in Blood

32462

128497

1.61

307.65

6.1

5.8

0.04

e9/l

1.01

27998

111928

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

52900

240832

1.66

307.65

6.0

5.1

39.49

39.33

mmol/mol

3.05

48966

224370

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

50355

197185

2.28

307.65

4.4

3.6

14.47

14.80

pmol/l

152.00

46044

179574

(3023103) Potassium [Moles/volume] in Serum or Plasma

60057

275588

2.18

307.65

17.7

14.0

3.95

3.96

mmol/l

22.44

58426

267505

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

968

580

8.82

307.65

1.9

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

30165

111399

1.74

307.65

3.0

2.8

110.75

126.64

ug/l

15.83

27775

104161

(3013826) Glucose [Moles/volume] in Serum or Plasma

36412

148470

1.60

307.65

4.9

4.4

6.68

6.69

mmol/l

0.71

34081

137264

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

54668

254557

1.62

307.65

14.1

11.5

85.85

83.41

ml/min/173m2

109.03

45146

208010

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

47915

195373

1.95

307.65

7.4

7.2

77.12

77.75

u/l

2.10

44975

184470

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27621

98688

1.78

307.65

2.4

2.2

3363.46

76.49

nmol/l

0.50

24937

89464

(3037467) Urinalysis macro (dipstick) panel - Urine

42270

181555

1.57

307.65

4.6

3.9

—

(3028300) Cannabinoids [Presence] in Urine

4872

10335

2.57

307.65

2.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

13903

48839

1.61

307.65

1.4

2.35

2.39

g/l

1.22

8121

30878

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

56843

242787

2.35

307.65

5.5

4.2

2.03

2.15

mu/l

0.63

52754

223301

(3009508) Creatinine [Moles/volume] in Urine

20068

76343

1.53

307.65

3.4

3.2

7.84

8.07

mmol/l

0.62

16901

65253

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

55879

257131

1.75

307.65

4.8

4.0

5.96

5.86

mmol/l

49.84

51131

236574

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

58626

275723

1.80

307.65

15.9

12.2

22.44

23.98

mg/l

21.16

47622

213461

(3019309) Folate [Moles/volume] in Red Blood Cells

13952

38292

2.13

307.65

1.8

1.7

1150.31

1150.36

nmol/l

0.00

10547

28993

(3001604) Monocytes [#/volume] in Blood

32357

128232

1.60

307.65

6.1

5.8

0.58

e9/l

0.88

27948

111767

(3021960) Folate [Moles/volume] in Serum or Plasma

16215

49658

1.92

307.65

1.6

1.5

20.10

20.19

nmol/l

0.29

14065

42717

(3021589) Normoblasts [#/volume] in Blood

27649

115795

1.42

307.65

9.9

9.0

0.00

e9/l

1.25

22394

95577

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10825

37486

1.60

307.65

3.2

3.6

0.82

mmol/l

3.23

10028

35243

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

29122

105600

1.77

307.65

5.7

6.1

1.21

mmol/l

4.11

26487

96535

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23347

81062

1.77

307.65

3.4

3.1

33.45

33.93

u/l

0.23

21940

77198

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1211

639

10.05

307.65

13.1

14.2

848.00

1621.21

nmol/l

0.44

1177

615

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

31811

117249

1.78

307.65

6.3

6.7

1.21

mmol/l

1.62

26833

99919

(3023368) Bacteria identified in Blood by Culture

17179

64786

1.51

307.65

4.5

4.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14594

47030

1.79

307.65

1.7

1.6

18755651.17

39330184.60

pmol/l

5.06

11986

39329

(3015377) Calcium [Moles/volume] in Serum or Plasma

22910

76199

1.86

307.65

3.0

3.5

2.35

mmol/l

0.44

20152

67285

(36304419) Bacteria [Presence] in Urine

17536

66606

1.50

307.65

3.2

3.0

—

(3013115) Eosinophils [#/volume] in Blood

33400

133005

1.61

307.65

6.6

5.9

0.19

e9/l

0.57

29260

117319

(3006504) Eosinophils/100 leukocytes in Blood

30287

121189

1.55

307.65

6.2

6.0

2.84

2.86

0.88

28195

113817

(3027944) Amphetamines [Presence] in Urine

4716

10263

2.50

307.65

2.8

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

31236

126225

1.54

307.65

6.3

6.0

28.24

28.10

1.31

29190

119066

(3027008) Opiates [Presence] in Urine

4852

10319

2.57

307.65

2.8

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

60729

292719

1.78

307.65

17.6

14.1

75.90

77.53

umol/l

28.81

60710

292569

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

23453

91081

1.53

307.65

3.8

3.2

55.86

60.04

ng/l

0.16

15050

59521

(3019069) Monocytes/100 leukocytes in Blood

30425

121914

1.55

307.65

6.6

6.2

8.40

8.58

16.52

28373

114664

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17445

58763

1.74

307.65

2.3

2.2

2.88

2.93

mg/l

1.74

14708

50466

(3024561) Albumin [Mass/volume] in Serum or Plasma

27853

103121

1.69

307.65

4.5

4.9

35.92

35.61

g/l

14.91

25745

95989

(3030467) Casts [#/volume] in Urine by Automated count

17878

68231

1.50

307.65

3.3

3.0

0.41

e6/l

0.05

13561

51545

(3016879) Cocaine [Presence] in Urine

4681

9208

2.78

307.65

2.9

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

3236

2116

8.33

307.65

3.3

2.4

—

(3026008) Bacteria identified in Urine by Culture

19020

72528

1.51

307.65

3.3

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

30567

120588

1.59

307.65

6.5

6.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

1153

424

14.42

307.65

11.6

14.2

0.61

0.64

mmol/l

2.27

1059

394

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

43593

179883

1.74

307.65

3.8

2.7

50.21

44.95

u/l

22.27

40682

169400

(1001926) Buprenorphine [Presence] in Urine by Screen method

4199

7068

3.24

307.65

3.0

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19932

69899

1.69

307.65

2.3

2.0

229.72

207.22

u/l

1.23

18626

65696

(3031040) Bacteria [#/volume] in Urine by Automated count

40851

170889

1.62

307.65

4.9

3.9

1744.14

1096.64

e6/l

1.19

638

2358

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

16198

55761

1.68

307.65

1.3

1.33

1.92

u/ml

7.72

4230

15482

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

663

384

9.09

307.65

2.4

2.6

148.92

157.61

nmol/l

0.57

563

334

(3002582) Erythrocytes [#/volume] in Urine

19439

75178

1.49

307.65

3.4

3.1

77.55

99.15

e6/l

1.02

14870

57385

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12391

39933

1.76

307.65

2.8

3.1

2.44

2.45

mmol/l

11.09

10701

34907

(40761511) CBC panel - Blood by Automated count

59875

290344

1.64

307.65

15.0

11.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

2098

1968

5.71

307.65

5.6

4.4

367.43

369.70

umol/l

0.21

1821

1682

(3015736) pH of Urine

25383

103241

1.45

307.65

3.5

3.1

5.91

5.86

1.64

1831

8726

(3019198) Lymphocytes [#/volume] in Blood

33312

132788

1.61

307.65

6.2

5.8

1.96

1.92

e9/l

2.07

29440

118222

(3018418) pH of Serum or Plasma

19386

67907

1.69

307.65

3.8

4.3

7.40

0.64

3689

12824

(3022217) INR in Platelet poor plasma by Coagulation assay

27817

113926

1.46

307.65

13.6

14.2

1.20

1.27

inr

16.72

8361

33061

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12694

27435

2.74

307.65

2.2

1.5

1.53

1.36

84.97

11097

24638

(3018095) Leukocytes [#/volume] in Urine

22530

88991

1.48

307.65

3.8

3.5

85.91

96.46

e6/l

1.00

15918

62023

(3036180) Methadone [Presence] in Urine

907

606

7.90

307.65

2.6

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

21734

75615

1.74

307.65

2.8

2.5

61.58

62.90

u/l

0.13

19834

70314

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7380

19481

2.10

307.65

2.1

2.3

370.65

378.88

nmol/l

2.50

6697

18089

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2208

3424

3.45

307.65

1.5

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

9423

30465

1.71

307.65

2.3

2.6

123.20

140.84

ug/g

4.39

7307

24462

(3009261) Glucose [Presence] in Urine by Test strip

30231

130782

1.37

305.93

3.9

3.3

0.00

estimate

0.08

5806

23299

(3033658) Prothrombin time (PT) actual/Normal

16265

63494

1.44

295.99

4.1

3.8

91.91

89.66

23.15

15802

61972

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6282

19877

1.72

284.14

2.5

2.1

12.61

12.38

nmol/l

1.29

5538

18125

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

635

547

6.11

271.34

2.3

1.6

144.29

112.08

umol/l

1.11

312

262

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1056

1487

3.75

267.84

1.6

1.3

1.46

1.30

promille

1.97

803

1193

(3022948) Iron [Moles/volume] in Serum or Plasma

10419

37879

1.51

266.37

2.3

2.6

13.42

13.88

umol/l

0.40

9566

35540

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8726

30546

1.56

264.25

5.1

6.5

1.03

1.04

mmol/l

2.56

8055

28609

(3013512) EKG study

17228

69286

1.40

258.97

4.0

3.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9624

34795

1.52

250.92

2.3

2.6

2.38

2.33

g/l

16.76

8731

32446

(3042517) Benzodiazepines panel - Urine

286

25.40

248.65

3.2

1.6

—

(3019150) Specific gravity of Urine by Refractometry

14123

55222

1.42

246.94

4.1

3.6

1.02

kg/l

0.67

1927

8831

(3021387) Prolactin [Units/volume] in Serum or Plasma

3416

9309

1.96

246.17

1.7

1.6

326.89

291.80

mu/l

4.10

3039

8504

(3002385) Erythrocyte distribution width [Ratio]

50578

240916

1.37

246.08

19.0

14.4

14.94

14.91

0.10

49668

236434

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7865

27488

1.56

237.73

2.6

2.8

7.64

9.06

umol/l

6.21

6615

24201

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12076

46223

1.44

235.34

3.8

3.5

309.53

607.85

ng/l

10.49

8687

35038

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4755

14676

1.74

232.33

2.9

3.6

4.45

4.56

pmol/l

8.80

4141

13293

(36660697) Celiac disease serology panel - Serum

6010

19820

1.64

230.29

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2163

5047

2.28

230.15

2.1

1.8

193.32

197.22

pmol/l

0.81

2038

4817

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6393

21499

1.61

226.45

2.3

0.22

0.21

g/l

8.23

5838

20168

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7306

25409

1.56

224.65

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7257

25281

1.56

221.28

1.8

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

8115

29043

1.52

219.05

1.8

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5099

16339

1.68

217.29

1.7

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2862

7674

1.99

215.09

1.9

1.6

38.88

41.87

nmol/l

7.60

2786

7510

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11057

42310

1.43

213.13

1.3

31.18

36.78

iu/ml

0.86

3110

14057

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8889

32620

1.49

212.40

2.4

2.7

22.64

23.15

2.47

7558

28034

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

56159

274065

1.40

210.22

5.0

4.4

2.75

2.79

mmol/l

19.35

51720

255657

(3017143) Hepatitis C virus Ab [Presence] in Serum

8901

32752

1.48

209.63

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4558

14337

1.71

207.42

3.3

3.6

5.19

5.11

kpa

9.58

4325

13548

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16012

65551

1.36

206.79

2.9

3.0

1141.22

1499.14

ng/l

19.77

13190

56232

(3009343) pH of Capillary blood

4507

14154

1.71

206.23

3.3

3.6

7.41

7.42

1.02

624

1752

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4367

13663

1.71

202.37

3.3

3.6

1.68

1.60

mmol/l

0.74

3285

9837

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10887

41905

1.42

201.92

2.8

2.7

1.36

1.09

e6/l

0.52

6046

23848

(3037522) Nuclear Ab [Titer] in Serum

9110

33935

1.46

200.93

1.4

1.3

474.40

567.54

titre

4.46

1720

7002

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15820

65051

1.35

196.76

1.7

1.6

1.50

1.33

mmol/l

69.96

13297

55341

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2311

5940

2.07

194.12

1.4

286.19

271.79

ug/g

1.74

1282

3494

(3029937) Albumin [Presence] in Urine by Test strip

16533

68722

1.34

190.21

4.3

3.6

0.00

estimate

4.38

5800

22886

(1002224) Polysomnography panel

3343

9847

1.81

189.54

1.1

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10311

39714

1.42

189.11

1.3

1.2

9.63

12.90

u/ml

4.36

3838

15914

(46235355) HIV 1 and 2 tests - Meaningful Use set

14067

57092

1.36

188.94

2.0

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1801

4232

2.25

188.20

2.6

2.7

33.36

33.95

umol/l

0.34

1639

3818

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10220

39412

1.42

185.78

3.0

2.8

2.93

2.68

e6/l

1.19

5387

21501

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

55210

269961

1.36

184.97

4.5

4.0

4.62

4.68

mmol/l

36.40

51107

253190

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

23078

100940

1.29

182.26

4.1

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

62811

314557

1.55

182.07

24.3

17.6

40.57

40.69

0.38

59197

295318

(3007461) Platelets [#/volume] in Blood

62841

314871

1.55

178.99

24.2

17.5

255.12

250.32

e9/l

60.38

61342

306245

(3012516) Albumin [Mass/volume] in Urine

16932

71130

1.32

178.95

3.3

359.34

403.07

mg/l

0.58

10785

46231

(3020682) Albumin/Creatinine [Ratio] in Urine

17736

75058

1.32

177.68

3.9

8.89

9.70

mg/mmol

1.09

11070

48581

(3019225) pH of Specimen

6385

22650

1.52

176.81

3.9

4.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

5845

20372

1.54

175.24

6.6

7.2

1.38

1.35

mmol/l

1.55

5664

19878

(3011397) Hemoglobin [Presence] in Urine by Test strip

14387

59215

1.34

174.00

3.7

3.3

—

(3035941) MCH [Entitic mass]

62858

315200

1.54

173.71

24.1

17.4

30.28

30.22

12.50

61951

310730

(3024731) MCV [Entitic volume]

62860

315240

1.54

173.06

24.1

17.4

90.80

90.58

26.82

61952

310756

(3026361) Erythrocytes [#/volume] in Blood

62866

315277

1.54

173.05

24.2

17.5

4.51

4.54

e12/l

30.10

61185

305775

(3010813) Leukocytes [#/volume] in Blood

62872

315316

1.54

173.00

24.2

17.5

6.86

6.69

e9/l

48.39

61198

305789

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

54727

267955

1.34

171.72

4.5

4.0

1.40

1.46

mmol/l

194.58

50353

250387

(3000963) Hemoglobin [Mass/volume] in Blood

62874

315418

1.54

170.91

24.3

17.6

135.75

136.41

g/l

23.59

61978

310958

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

40382

190225

1.27

168.99

3.4

3.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

53026

258597

1.32

168.97

4.0

3.6

1.39

1.25

mmol/l

260.07

48414

240276

(4200892) Spirometry reversibility

4952

16897

1.57

162.25

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7772

29212

1.44

160.34

7.2

6.4

—

(3002032) Base excess in Venous blood by calculation

6059

21780

1.50

156.47

3.9

4.1

1.96

1.78

mmol/l

3.18

5164

18442

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5310

18582

1.53

155.37

3.7

3.9

1.23

mmol/l

0.26

4515

16411

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5737

20427

1.51

154.94

2.2

1.9

—

(3012544) pH of Venous blood

6254

22676

1.48

154.76

3.9

4.0

7.37

7.38

0.37

171

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6067

21867

1.49

154.56

3.9

4.0

5.90

5.81

kpa

8.89

5839

21254

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4709

16062

1.57

154.19

2.1

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2025

5423

1.98

151.93

1.3

499.24

546.50

mg/l

1.71

1918

5187

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4028

13323

1.61

149.68

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2686

7956

1.79

148.80

1.4

8.46

9.45

u/l

3.66

2149

6584

(3003396) Base excess in Arterial blood by calculation

7080

26573

1.44

146.16

7.2

7.3

1.18

0.91

mmol/l

6.02

5684

20905

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3923

13031

1.61

143.08

1.7

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7057

26571

1.43

142.98

7.2

7.4

5.15

5.05

kpa

13.93

6711

25304

(3027801) Oxygen [Partial pressure] in Arterial blood

7053

26556

1.43

142.89

7.2

7.3

11.84

12.78

kpa

37.77

6711

25288

(3042936) Bacteria identified in Isolate by Culture

8879

34882

1.38

140.73

2.1

1.9

—

(3000494) Fungus identified in Specimen by Culture

7516

28709

1.41

140.44

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

18858

82448

1.27

139.36

2.4

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1799

4763

2.00

139.18

1.4

1.5

1750.39

1607.89

e6/l

0.07

1477

3862

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

12887

53640

1.31

139.16

1.7

1.5

—

(3025941) Bacteria identified in Stool by Culture

4200

14275

1.57

139.07

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4943

17428

1.52

139.02

1.2

127.46

153.64

iu/ml

3.60

1719

6755

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1795

4761

1.99

138.18

1.3

1.4

19.86

36.44

e6/l

1.98

1392

3683

(3022145) Colonoscopy Study observation

7232

27525

1.42

137.69

1.3

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

5011

17814

1.51

135.43

3.4

3.3

4.66

4.62

kpa

0.50

4793

17252

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3429

11178

1.63

134.57

4.0

4.6

24.25

24.01

mmol/l

3.92

3329

10942

(3022313) Gas panel - Capillary blood

3205

10267

1.66

134.53

3.4

3.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1782

4789

1.97

132.24

1.2

1.3

3.78

3.71

mmol/l

1.63

1679

4496

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6386

23943

1.43

131.65

3.8

3.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2541

7678

1.76

131.46

2.2

2.4

449.50

603.11

ug/l

1.56

2362

7185

(3027945) Reticulocytes/100 erythrocytes in Blood

6931

26428

1.41

130.06

2.4

2.7

1.78

1.73

3.05

6011

23585

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4014

13728

1.56

129.06

1.6

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2834

8914

1.69

127.20

3.5

3.9

24.86

24.71

mmol/l

1.97

2650

8259

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9353

37588

1.35

127.13

2.0

2.2

29.69

29.88

2.22

9059

36509

(3023323) Follitropin [Units/volume] in Serum or Plasma

3590

12024

1.59

126.07

1.4

1.3

23.62

27.34

iu/l

8.77

3007

10437

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1222

2895

2.23

125.06

1.6

—

(3000991) Gas panel - Venous blood

5431

19992

1.45

122.92

7.9

8.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1866

5298

1.86

117.83

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4514

16182

1.49

116.44

1.2

—

(3016502) Oxygen saturation in Arterial blood

6243

23818

1.41

115.89

7.6

7.7

95.18

95.85

10.90

6019

22859

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4113

14504

1.51

114.71

6.5

7.4

24.94

24.64

mmol/l

5.24

4061

14392

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2988

9855

1.61

111.43

1.1

1.10

14.82

u/ml

2.16

144

(40761536) Microorganisms panel - Urine sediment

5706

21571

1.42

111.29

4.2

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14419

62415

1.26

110.56

2.3

2.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2214

6767

1.73

109.85

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2231

6835

1.73

109.79

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2236

6857

1.73

109.65

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

16355

72078

1.24

106.39

3.5

3.0

—

(3010421) pH of Blood

1983

5940

1.76

105.37

3.9

3.7

7.42

3.12

1800

5443

(3044290) Cell count panel - Cerebral spinal fluid

1624

4590

1.87

103.90

1.3

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2591

8424

1.63

102.16

1.7

—

(1616796) Gas panel - Central venous blood

1747

5085

1.81

101.97

3.4

3.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3479

12141

1.52

101.47

1.1

133.54

208.08

titre

0.88

383

(3019060) Gas panel - Arterial blood

4118

14970

1.46

98.47

4.8

—

(3008295) Osmolality of Serum or Plasma

853

1917

2.34

98.35

1.6

1.5

280.62

280.75

mosm/kgh2o

0.05

661

1542

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4530

16777

1.44

98.30

2.4

2.3

23.23

22.57

au/ml

0.15

330

1431

(3027315) Oxygen [Partial pressure] in Blood

1765

5215

1.79

98.11

4.0

3.8

8.74

8.69

kpa

0.51

1714

5106

(3012501) Base excess in Blood by calculation

1755

5182

1.79

97.77

3.9

3.8

2.49

2.43

mmol/l

0.34

1204

3427

(3013290) Carbon dioxide [Partial pressure] in Blood

1755

5183

1.79

97.70

3.9

3.8

5.07

4.95

kpa

7.53

1704

5074

(3026493) Urate [Moles/volume] in Serum or Plasma

15308

67562

1.24

96.41

2.5

2.6

3337.40

4509.03

umol/l

3.39

13199

60110

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4163

15265

1.45

95.10

1.3

42.37

54.17

au/ml

2.42

174

816

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2258

7233

1.65

94.22

1.9

1.7

—

(3003181) Sodium [Moles/volume] in Urine

1246

3327

1.97

94.03

1.4

60.73

65.17

mmol/l

2.69

940

2697

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5686

22085

1.38

93.77

8.0

8.1

122.95

121.72

g/l

4.04

5537

21456

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

563

1055

2.80

92.68

1.0

765.73

731.83

ng/l

0.77

368

738

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

561

1050

2.80

92.55

1.0

290.05

377.96

ng/l

1.73

381

766

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

563

1057

2.79

92.38

1.0

41.69

42.25

ng/l

0.09

372

763

(3005322) IgE [Units/volume] in Serum or Plasma

4359

16246

1.43

91.15

1.3

301.24

251.64

u/ml

0.82

4008

15070

(3005719) IgG [Mass/volume] in Serum or Plasma

4890

18613

1.40

90.82

2.3

2.8

10.49

10.72

g/l

2.82

4421

17171

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5126

19716

1.39

89.48

2.4

2.2

6.40

7.87

ug/l

4.84

4314

17378

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2654

8977

1.57

88.72

1.6

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

628

1281

2.57

88.42

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1626

4840

1.77

88.15

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1625

4837

1.77

88.10

1.4

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26962

126461

1.19

87.97

2.6

2.5

—

(3007463) Buprenorphine [Presence] in Urine

31.36

87.71

7.7

2.4

—

(40761535) Cells panel - Urine sediment

5077

19563

1.38

87.58

3.5

3.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4542

17235

1.40

85.67

3.5

4.3

86.05

94.20

ng/l

6.37

3896

15032

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3267

11679

1.48

84.60

2.4

2.3

4907.95

6484.28

u/l

2.05

1131

5133

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3390

12265

1.47

82.63

8.8

9.7

24.39

24.20

mmol/l

2.50

3246

11869

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

175

134

6.83

82.58

6.2

9.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1826

5732

1.68

82.13

2.9

3.0

24.78

24.43

mmol/l

2.98

1789

5603

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2684

9262

1.53

82.04

1.2

0.73

0.93

u/ml

0.46

214

786

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1930

6184

1.65

80.34

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

1587

4838

1.73

79.28

2.5

2.4

16.70

16.55

0.65

830

2458

(40768804) Tissue Pathology biopsy report

22958

106957

1.18

77.91

2.1

2.0

—

(3052851) Hemolysis interference index of Serum or Plasma

2155

7162

1.59

77.48

3.2

3.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

2045

6720

1.61

77.02

1.2

1.3

79.20

124.36

titre

3.23

187

636

(3023520) Reticulocytes [#/volume] in Blood

4978

19506

1.36

76.95

2.3

2.7

71.82

68.61

e9/l

6.65

3661

14787

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

489

944

2.72

76.43

1.9

1.4

2305951.24

1899136.41

iu/ml

0.22

(3028026) IgM [Mass/volume] in Serum or Plasma

3843

14447

1.41

76.14

1.7

1.9

1.30

1.31

g/l

0.04

3474

13259

(3002179) Metamyelocytes/100 leukocytes in Blood

4878

19160

1.35

74.13

3.7

4.0

0.68

0.00

1487

6154

(3028271) Lactate [Moles/volume] in Capillary blood

1232

3554

1.82

73.95

2.0

1.8

1.76

1.74

mmol/l

0.20

1210

3457

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3857

14603

1.40

73.30

8.9

9.3

1.49

1.33

14.10

3836

14493

(3017181) Myelocytes/100 leukocytes in Blood

5297

21103

1.34

73.28

3.9

4.2

0.90

0.95

0.50

1728

7145

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3851

14599

1.40

72.63

8.9

9.4

0.67

0.10

3829

14503

(3004588) Protein electrophoresis panel - Serum or Plasma

3954

15092

1.39

71.62

2.2

2.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2955

10699

1.46

71.54

3.1

2.9

1.43

1.21

16.89

2939

10644

(3017732) Neutrophils [#/volume] in Blood

4537

17728

1.36

71.17

3.3

2.5

5.03

4.93

e9/l

0.17

3642

14514

(3020891) Body temperature

2532

8903

1.50

70.80

5.0

4.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7230

30224

1.28

70.08

4.5

4.2

31.19

32.48

17.78

5102

21286

(3028626) Oxygen [Partial pressure] in Capillary blood

1696

5445

1.64

70.02

2.9

3.1

8.27

8.39

kpa

1.89

1656

5308

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1231

3612

1.79

69.97

1.4

1.3

22.64

25.73

u/l

2.47

988

3057

(3014007) Fractional oxyhemoglobin in Arterial blood

3842

14653

1.39

69.87

9.0

9.5

93.37

94.11

9.04

3826

14601

(3020779) Urea [Moles/volume] in Serum or Plasma

5387

21667

1.32

69.63

6.5

8.1

8.95

10.04

mmol/l

22.85

5095

20618

(3034770) Mitochondria Ab [Titer] in Serum

1978

6610

1.58

69.44

1.2

1.3

836.49

1069.09

titre

0.59

198

(3000492) Spirometry study

6414

26458

1.29

68.90

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

5004

33667

0.76

68.77

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

5031

20110

1.33

67.80

4.0

4.2

0.09

0.11

1.70

1476

6190

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10926

48029

1.22

67.70

1.7

—

(3021901) Oxygen saturation in Capillary blood

1355

4154

1.72

66.37

2.6

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5310

21453

1.32

66.35

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3269

12239

1.41

66.04

2.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2871

10502

1.45

65.81

3.1

2.9

0.66

0.14

2860

10459

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3777

14517

1.38

65.45

7.4

6.9

24.83

24.40

mmol/l

9.41

3607

13758

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

732

1839

2.09

65.07

1.8

2.4

19.79

20.01

nmol/l

0.19

672

1766

(3020630) Protein [Mass/volume] in Serum or Plasma

4733

18871

1.33

64.77

2.3

2.7

66.64

66.56

g/l

0.27

4258

17293

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

879

2369

1.95

64.71

1.2

25.82

32.84

nmol/l

0.44

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1160

3448

1.77

63.20

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1137

3362

1.78

63.03

1.4

1.3

—

(3025159) Blasts/100 leukocytes in Blood

4761

19072

1.33

63.01

4.1

4.2

0.09

0.44

6.30

1210

5249

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

62.72

1.3

0.0

508.22

—

nmol/l

—

(3006653) Thiamine [Moles/volume] in Blood

454

937

2.54

62.65

1.3

1.2

142.54

134.83

nmol/l

2.21

454

937

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2672

9735

1.45

62.50

1.6

3.67

3.90

mg/l

0.60

2089

6613

(3023410) Appearance of Cerebral spinal fluid

831

2226

1.96

62.25

1.4

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7211

30553

1.26

61.98

1.7

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

2226

7841

1.50

61.63

4.3

4.1

1.37

1.39

mmol/l

0.36

2195

7689

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

180

205

4.59

59.17

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

876

2434

1.89

59.06

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1308

4105

1.68

58.87

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3613

14092

1.36

56.94

1.3

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1286

4063

1.66

56.46

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4781

19457

1.30

56.26

2.8

2.9

169.89

218.67

ng/l

11.85

4293

17721

(3004119) Hemoglobin [Mass/volume] in Venous blood

3638

14241

1.35

55.99

3.6

3.4

130.95

129.23

g/l

4.38

3545

13934

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2494

9228

1.43

53.62

1.9

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2699

10162

1.40

52.61

2.1

1.9

—

(3022806) Fractional oxyhemoglobin in Capillary blood

978

2924

1.76

52.31

1.9

1.7

89.79

90.05

0.63

962

2875

(3035637) Corticotropin [Mass/volume] in Plasma

951

2820

1.77

52.29

1.4

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1519

5101

1.57

52.21

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1601

5467

1.54

51.15

2.2

132.17

130.69

g/l

1.36

1195

3979

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

758

2111

1.88

50.83

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1906

6784

1.48

50.12

4.5

4.4

3.85

3.90

mmol/l

5.74

1896

6718

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2009

7318

1.45

46.94

1.1

3.00

6.56

u/ml

5.77

252

1013

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6587

28467

1.23

46.47

3.5

4.5

235.55

245.61

u/l

5.00

6145

27062

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2366

8917

1.40

45.80

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

1409

4823

1.54

44.55

3.3

3.5

—

(3003338) MCHC [Mass/volume]

48680

244448

1.14

44.15

21.0

15.1

332.87

332.95

g/l

1.08

48256

242394

(3008898) HLA-B27 [Presence]

2357

8943

1.39

43.85

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1190

3954

1.58

42.84

1.5

0.35

0.45

nmol/l

2.40

911

3191

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1958

7231

1.43

42.49

2.2

2.5

0.69

0.94

g/l

2.53

1684

6220

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1881

6905

1.43

42.18

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1646

5895

1.47

41.98

2.2

2.3

0.00

g/l

0.56

1477

5391

(3040151) Glucose [Moles/volume] in Capillary blood

862

2652

1.71

41.83

9.2

5.8

7.30

7.38

mmol/l

0.16

709

2151

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

697

2014

1.81

41.81

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

565

1523

1.94

41.78

3.2

29.75

25.49

mu/l

1.51

527

1431

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1795

6565

1.44

41.06

2.1

2.2

37.88

37.69

g/l

0.57

1568

5744

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

617

1727

1.87

40.87

1.3

1.2

1.99

2.11

mmol/l

1.59

575

1600

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4600

29458

0.80

40.62

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1617

5820

1.46

40.22

2.2

2.3

0.00

g/l

-0.00

1470

5381

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1753

6408

1.44

40.21

2.2

2.3

0.04

0.03

g/l

0.39

1580

5881

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2667

10477

1.34

39.89

4.2

3.9

49.99

47.66

4.80

2630

10372

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2066

7792

1.40

39.81

1.7

1.20

1.16

g/l

6.77

1958

7421

(3001019) Free T4 and TSH panel - Serum or Plasma

3540

14477

1.29

39.75

1.7

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2009

7562

1.40

39.16

1.7

0.24

0.23

g/l

2.42

1904

7165

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

619

1761

1.84

39.04

1.1

284.17

455.52

mg/l

0.52

544

1602

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

393

952

2.16

38.50

2.6

2.5

55.30

51.55

umol/l

1.36

330

826

(3027273) Bicarbonate [Moles/volume] in Venous blood

2862

11430

1.32

38.23

3.6

3.4

25.37

25.15

mmol/l

2.67

2768

11087

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

977

3190

1.61

37.86

1.8

6890.43

2892.17

titre

0.83

138

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2107

8047

1.38

37.68

2.2

2.3

2.92

2.94

g/l

0.30

1886

7248

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2098

8012

1.38

37.54

2.1

2.3

10.02

10.35

g/l

2.62

1858

7155

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

926

3031

1.60

35.55

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2648

10569

1.32

35.50

1.9

2.0

39.32

39.39

u/l

0.05

2367

9436

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2214

8610

1.35

35.36

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2216

8619

1.35

35.36

2.1

2.3

7.37

7.36

g/l

0.00

1996

7815

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

360

873

2.16

35.23

1.5

1.4

73.35

72.39

0.60

343

832

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1975

7552

1.38

35.06

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2209

8599

1.35

35.06

2.1

2.3

3.70

3.75

g/l

0.86

1990

7802

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

904

2952

1.61

35.05

1.4

—

(3016038) Potassium [Moles/volume] in Urine

467

1254

1.95

35.02

1.3

32.43

35.68

mmol/l

2.00

377

1118

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

323

752

2.25

34.81

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2354

9273

1.34

34.54

2.0

2.08

2.38

ug/l

0.44

2057

8230

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

106

123

4.50

34.36

1.1

1.4

59.34

42.87

mg/l

1.57

(3024522) Salmonella sp identified in Specimen by Organism specific culture

903

2965

1.60

34.25

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

352

856

2.15

34.24

1.5

1.4

496.60

770.41

mu/l

1.05

335

815

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

965

3227

1.57

33.91

1.3

0.24

0.26

nmol/l

0.12

186

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

703

2169

1.70

33.88

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

890

2925

1.60

33.64

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1774

6716

1.39

33.45

1.3

37.64

37.81

u/ml

0.01

420

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1224

4332

1.48

33.18

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

887

2923

1.59

33.16

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

886

2923

1.59

32.97

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

963

3246

1.56

32.72

1.3

1.03

1.39

nmol/l

0.24

921

3134

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2680

10850

1.30

32.40

1.4

1.6

15.42

14.06

u/ml

0.17

365

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1622

6085

1.40

32.27

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1645

6193

1.40

32.07

1.8

1.9

9.31

20.39

iu/l

0.51

588

2320

(3017509) Phencyclidine [Presence] in Urine

153

250

3.20

31.92

2.2

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3155

13104

1.27

31.22

9.6

9.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2690

10966

1.29

30.86

1.6

1.8

1.54

1.50

g/l

1.50

2249

9384

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

478

1355

1.85

30.63

1.3

1.2

5.22

5.31

umol/l

0.16

431

1264

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

308

743

2.17

30.62

2.9

3.0

28.92

28.98

umol/l

0.02

222

578

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

441

1220

1.89

30.42

1.1

3.08

6.97

nmol/l

1.29

253

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2148

8541

1.32

29.57

1.6

285.06

287.86

titre

0.02

358

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

304

741

2.15

29.49

1.4

13.78

15.55

pmol/l

4.77

251

643

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

872

2944

1.55

29.47

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

308

756

2.13

29.38

1.8

2.6

1.05

1.10

ug/l

0.17

285

715

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

346

891

2.03

29.20

2.6

2.3

—

(3006270) Folate [Moles/volume] in Blood

603

1864

1.69

28.96

1.2

1.1

377.69

356.59

nmol/l

1.54

518

1576

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1338

4956

1.42

28.65

1.2

34.48

46.30

u/ml

1.77

125

485

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.59

28.48

1.1

—

mmol/l

—

(3011985) Renin [Units/volume] in Plasma

927

3199

1.52

28.42

1.5

1.6

69.23

58.62

mu/l

0.77

821

2889

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

946

3286

1.51

28.13

1.1

1.48

1.50

g/l

0.84

837

2994

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

973

3406

1.50

27.90

1.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

27.78

1.3

0.0

145.55

—

nmol/l

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4639

20334

1.20

27.74

2.6

70.48

66.34

ml/min/173m2

8.44

1851

7836

(3013005) Retinol [Moles/volume] in Serum or Plasma

355

943

1.97

27.58

1.7

1.9

1.99

1.92

umol/l

0.80

327

891

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

606

1909

1.66

27.18

1.2

1.1

36.64

47.29

mg/l

5.25

504

1629

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

393

1094

1.88

26.70

1.3

65.69

63.66

0.13

133

(40768443) Skin Pathology biopsy report

2637

10940

1.27

26.32

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2315

9457

1.29

26.14

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3114

19860

0.81

26.00

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

583

1840

1.66

25.99

1.1

251.23

279.24

mg/l

1.80

514

1637

(43055514) Macroprolactin [Presence] in Serum or Plasma

268

655

2.14

25.91

1.4

—

(3023419) Bacteria identified in Sputum by Culture

945

3342

1.48

25.83

2.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3181

13516

1.24

25.80

2.7

0.31

0.27

e6/l

0.54

3092

13162

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

565

1778

1.66

25.48

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

427

1242

1.80

25.34

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2839

18227

0.80

25.23

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

417

1207

1.81

25.14

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1809

7185

1.32

25.13

1.9

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1608

6280

1.34

25.05

1.3

6.52

9.64

u/ml

1.55

256

996

(3045414) Leukocytes [Presence] in Urine

2697

11287

1.26

25.02

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

634

2066

1.61

24.97

1.3

1.49

1.37

nmol/l

1.59

563

1874

(3036489) Thrombin time

2388

9853

1.27

24.93

1.9

2.2

21.38

21.50

0.34

2071

8560

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.31

24.58

2.1

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

479

1457

1.72

24.47

1.7

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

521

1623

1.68

24.43

1.1

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1318

5008

1.38

24.42

2.0

2.1

0.88

0.80

nmol/l

2.81

1084

4225

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1747

6949

1.32

24.04

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

517

1615

1.68

24.00

1.1

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

847

2979

1.49

23.83

1.3

1.4

370.04

380.26

pmol/l

0.06

724

2605

(3024980) IgG subclass 4 [Mass/volume] in Serum

1105

4091

1.42

23.81

1.5

1.6

0.69

0.81

g/l

3.17

815

3105

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1580

6203

1.34

23.79

1.3

3.85

7.59

u/ml

1.66

160

671

(3022621) pH of Urine by Test strip

3860

16886

1.20

23.49

3.0

2.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

825

2898

1.49

23.36

2.0

25.83

27.48

mg/l

0.32

223

755

(3047181) Lactate [Moles/volume] in Blood

1918

7764

1.30

23.25

5.9

5.5

1.34

1.29

mmol/l

1.30

1687

6853

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9330

43762

1.13

22.90

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1416

5506

1.35

22.74

1.5

1.7

—

(3014271) Vancomycin [Susceptibility]

360

1028

1.83

22.72

3.2

2.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1205

8505

0.73

22.57

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1866

7560

1.30

22.48

1.4

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

412

1234

1.75

22.26

1.2

346.34

344.54

u/l

0.01

383

1158

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

405

1208

1.75

22.20

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1459

5721

1.34

22.18

1.5

1.6

—

(4146454) Self-monitoring of blood glucose

706

2428

1.52

22.12

2.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1736

6988

1.30

21.96

1.4

1.5

16.38

12.58

iu/ml

0.43

163

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

256

658

2.03

21.88

1.2

18.65

20.88

0.14

113

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

760

2677

1.49

21.29

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

956

3522

1.42

21.23

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1067

4016

1.39

20.99

3.3

3.2

63.98

65.76

1.72

1061

3999

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

351

1023

1.79

20.81

1.7

1.6

4.80

5.99

nmol/l

0.18

276

870

(3037121) Protein [Mass/volume] in Urine

2086

8658

1.27

20.78

3.0

3.3

0.31

0.33

g/l

0.42

901

4078

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2251

9436

1.25

20.61

1.3

236.37

227.28

miu/ml

0.51

972

4481

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

171

383

2.33

20.36

1.5

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1296

5065

1.34

20.18

1.2

13.33

15.78

u/ml

0.08

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1440

5718

1.32

20.12

1.1

2.05

2.33

u/ml

0.42

730

2886

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.54

20.04

1.4

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2349

9931

1.24

19.96

5.3

4.8

1.84

1.65

8.55

2197

9300

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

417

1294

1.69

19.95

1.1

1.02

1.09

u/l

1.40

182

590

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

418

1298

1.69

19.95

1.4

1.5

5.78

6.07

u/l

0.20

350

1087

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

649

2249

1.51

19.70

1.4

1.3

181.95

191.75

pmol/l

0.22

649

2249

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

626

2157

1.52

19.52

1.2

1.4

—

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1940

8044

1.27

19.51

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1087

4159

1.37

19.41

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1251

4894

1.34

19.37

1.1

1.13

1.10

u/ml

0.06

546

2104

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1125

4331

1.36

19.33

3.0

3.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1300

5117

1.33

19.32

1.2

2.15

6.32

u/ml

2.89

426

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

831

3038

1.43

19.30

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2303

9754

1.24

19.26

5.4

4.9

0.90

0.89

0.17

2164

9131

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

312

899

1.82

19.24

1.8

1.9

28.51

28.62

umol/l

0.07

300

869

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

614

4720

0.68

19.13

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1070

4096

1.37

19.06

1.6

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

530

1772

1.57

18.91

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1659

6783

1.28

18.70

2.0

2.1

11.05

10.90

mg/l

0.17

1560

6346

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

377

1161

1.70

18.59

1.1

9.11

10.57

u/ml

0.25

210

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

844

3120

1.42

18.47

6.6

6.2

11.39

11.46

mg/l

0.14

767

2867

(3019977) pH of Arterial blood

387

1203

1.68

18.45

3.1

2.2

7.42

0.42

116

400

(3010838) Calcium [Moles/time] in 24 hour Urine

1104

4270

1.36

18.44

1.9

5.09

5.21

mmol/24h

0.51

989

3803

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

181

435

2.17

18.41

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1298

5150

1.32

18.29

1.1

5.61

6.14

u/ml

0.44

688

2706

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

439

1416

1.62

18.19

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

7116

33264

1.13

18.15

1.8

1.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1050

4040

1.36

18.14

2.2

2.1

7.21

6.71

titre

0.07

107

(3024139) IgG subclass 3 [Mass/volume] in Serum

715

2572

1.46

18.12

1.3

1.4

0.38

0.41

g/l

2.01

495

1794

(3027135) IgG subclass 1 [Mass/volume] in Serum

715

2575

1.45

18.02

1.3

1.4

6.36

6.92

g/l

3.41

494

1794

(4062490) Immunoglobulin typing, IgG

715

2576

1.45

17.98

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

714

2575

1.45

17.87

1.3

1.4

2.88

3.04

g/l

1.59

494

1794

(3044242) Glucose [Moles/volume] in Arterial blood

329

988

1.74

17.75

2.3

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

1616

6630

1.28

17.75

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

523

1778

1.54

17.40

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

430

1396

1.61

17.39

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

741

2706

1.43

17.37

1.1

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1223

4852

1.32

17.27

1.2

144.55

132.64

titre

0.07

106

(40757494) Bilirubin.total [Moles/volume] in Blood

375

1178

1.67

17.24

2.0

2.2

13.64

27.39

umol/l

1.80

107

(3039443) Prostate specific Ag panel - Serum or Plasma

772

5590

0.72

17.14

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

489

1647

1.55

16.97

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

203

528

2.01

16.96

1.3

1.2

129.93

127.62

nmol/l

0.06

142

411

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

486

1638

1.55

16.82

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

466

1556

1.57

16.80

1.4

1.6

25.74

25.52

u/ml

0.03

102

300

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1377

9158

0.78

16.71

1.5

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

856

3230

1.39

16.71

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

396

1273

1.63

16.68

1.7

1.5

1.26

1.22

nmol/l

0.25

298

1039

(3020717) Zinc [Moles/volume] in Serum or Plasma

360

1129

1.67

16.67

1.6

1.5

20.40

26.35

umol/l

3.58

340

1079

(3042631) Mycobacterium sp identified in Specimen

837

3150

1.39

16.60

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

511

1748

1.53

16.57

2.8

2.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1909

12207

0.81

16.33

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1723

7207

1.25

16.16

3.0

3.4

38.37

46.51

mg/l

1.37

1367

5870

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1205

4825

1.31

15.97

1.1

1.64

2.22

u/ml

1.65

624

2379

(3034860) Kappa light chains.free [Mass/volume] in Serum

1722

7214

1.25

15.94

3.0

3.4

51.92

67.01

mg/l

1.04

1370

5871

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

236

667

1.85

15.58

2.9

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

236

667

1.85

15.58

2.9

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

191

2.68

15.53

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

407

1342

1.59

15.52

1.2

1.3

423.20

401.80

titre

0.03

100

(3001186) Copper [Moles/volume] in Serum or Plasma

201

539

1.95

15.49

1.4

1.3

16.64

16.52

umol/l

0.12

173

489

(3049717) Cytology report of Urine Cyto stain

2135

9185

1.22

15.45

2.5

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1672

7008

1.25

15.42

2.9

3.4

5.68

4.56

ratio

0.10

123

555

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1814

7675

1.24

15.38

2.2

2.7

186.87

185.77

0.19

1709

7296

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

395

1296

1.59

15.38

1.2

1.3

70.30

84.59

titre

0.30

109

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1454

6003

1.27

15.24

2.2

2.4

115.93

113.33

ug/min

0.06

855

3688

(3041806) Other cells [#/volume] in Blood by Manual count

371

1202

1.61

15.21

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1328

5427

1.28

15.12

1.2

1.3

261.46

258.78

u/ml

0.13

829

3508

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1403

5774

1.27

15.10

1.2

1.3

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

6.38

15.02

1.5

1.0

1991.14

—

umol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

945

3689

1.34

14.97

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

780

2955

1.38

14.93

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

336

1073

1.64

14.61

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

336

1073

1.64

14.61

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

853

3299

1.35

14.38

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

166

427

2.03

14.37

1.8

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

292

905

1.69

14.22

1.1

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1957

8421

1.22

14.17

2.0

2.5

93.89

91.88

3.29

1859

8099

(3038177) Helicobacter pylori Ab [Presence] in Serum

1100

4432

1.30

14.00

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

410

1389

1.54

13.98

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

239

704

1.77

13.90

1.2

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

167

2.69

13.78

1.5

1.3

10.53

16.24

pmol/l

0.86

140

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1058

7089

0.78

13.72

1.4

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

671

2522

1.39

13.52

1.2

60.91

65.31

u/l

0.62

590

2286

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1025

4120

1.30

13.30

1.1

11.03

12.47

au/ml

0.24

286

(3002256) Pathology report gross observation

7178

34140

1.11

13.30

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

165

437

1.97

13.25

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

674

2548

1.38

13.14

1.5

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

669

2528

1.39

13.08

3.3

—

(44813793) Dust mix specific IgE antibody measurement

504

1815

1.45

12.88

1.1

—

(3017569) Oxygen content in Arterial blood

297

952

1.63

12.80

2.5

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

698

2668

1.37

12.75

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

688

1.74

12.53

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

454

1616

1.47

12.34

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2835

12780

1.16

12.18

2.9

3.3

53.01

50.79

u/ml

0.07

2730

12354

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1982

8671

1.20

12.15

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1610

10158

0.82

12.12

1.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

126

312

2.11

12.12

1.0

81.33

81.13

ug/l

0.02

108

256

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

503

1834

1.43

12.08

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

492

1787

1.44

12.07

1.3

1.4

11.66

12.39

umol/l

1.61

460

1710

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

591

2221

1.39

11.99

3.8

3.9

—

(3001556) Androgen free Index in Serum or Plasma

116

279

2.17

11.98

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

566

2114

1.40

11.90

1.2

158.25

199.07

titre

0.60

353

(3037756) Immunofixation for Serum or Plasma

1146

4744

1.27

11.87

1.5

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1875

8182

1.20

11.82

3.2

0.34

u/ml

0.14

1070

4614

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

564

2109

1.40

11.79

1.2

198.33

164.00

titre

0.13

(3014051) Protein [Presence] in Urine by Test strip

1525

6525

1.22

11.75

2.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

280

906

1.62

11.69

1.1

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

960

3896

1.29

11.66

1.3

1.5

—

(3051651) Icteric interference index of Serum or Plasma

416

1475

1.47

11.57

3.8

4.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

487

1781

1.43

11.54

1.2

1.3

2.27

1.84

u/ml

0.32

274

1006

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

463

1678

1.44

11.52

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1012

4147

1.28

11.41

1.1

5.21

4.19

u/ml

0.55

475

2016

(4034850) Laboratory test

1875

8211

1.20

11.39

10.6

8.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

362

1257

1.51

11.16

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

746

2943

1.33

11.16

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

17469

86785

1.07

11.15

4.6

4.7

2.64

3.41

ug/l

2.16

15366

78511

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

187

549

1.78

11.12

1.8

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

362

1264

1.50

10.89

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1285

5446

1.24

10.88

3.0

3.5

—

(3038026) Centromere Ab [Units/volume] in Serum

515

1924

1.40

10.87

1.2

41.34

40.02

u/ml

0.03

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

928

3787

1.28

10.84

1.2

1.3

33.05

35.55

u/l

0.18

796

3315

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

990

4074

1.27

10.82

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

162

460

1.84

10.73

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

675

2640

1.34

10.73

3.1

3.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1831

8050

1.19

10.68

2.5

2.8

3.66

3.59

g/l

1.11

1727

7699

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

405

1453

1.46

10.66

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

953

3913

1.28

10.61

1.1

120.76

116.74

3.29

862

3557

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1007

4163

1.27

10.61

1.1

59.92

848.53

iu/ml

1.35

232

929

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1202

7694

0.81

10.52

1.4

1.5

—

(3039000) Anion gap in Blood

1270

5400

1.23

10.45

7.1

6.5

11.24

11.28

mmol/l

0.16

1139

4848

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1507

9430

0.83

10.45

1.4

1.5

—

(3018572) Chloride [Moles/volume] in Blood

1270

5401

1.23

10.43

7.2

6.5

105.00

105.28

mmol/l

1.20

1139

4850

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1513

9460

0.83

10.40

1.4

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.97

10.36

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1202

7676

0.81

10.29

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1273

5423

1.23

10.29

1.5

1.6

—

(3021788) Differential panel - Synovial fluid

1067

4458

1.25

10.29

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

939

3867

1.27

10.23

1.1

—

(3020491) Glucose [Moles/volume] in Blood

509

1919

1.39

10.22

1.8

1.7

6.95

6.55

mmol/l

1.86

373

1411

(3023430) Cat dander IgE Ab [Units/volume] in Serum

940

3872

1.27

10.22

1.1

7.23

4.66

u/ml

1.54

400

1637

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

462

1713

1.41

10.22

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1519

9478

0.83

10.21

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1518

9471

0.83

10.20

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1234

7849

0.82

10.16

1.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

190

578

1.72

10.07

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

191

584

1.71

9.95

1.1

—

(3025130) Human papilloma virus identified in Specimen

890

3657

1.27

9.89

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

497

1881

1.38

9.78

1.2

76.74

67.82

u/ml

0.23

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

511

1943

1.38

9.78

1.1

61.57

66.41

u/ml

—

(3000012) Reticulocyte production index

808

3287

1.29

9.73

2.1

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

953

3959

1.26

9.69

1.1

2.40

3.12

u/ml

1.41

439

1996

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

601

2350

1.34

9.63

1.5

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

497

1888

1.38

9.58

1.2

40.08

45.86

u/ml

0.21

143

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

128

351

1.91

9.48

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

378

1372

1.44

9.44

1.4

1.6

7.82

8.61

ug/l

0.28

339

1243

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

579

1.69

9.35

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

476

1806

1.38

9.26

1.2

4.29

11.82

u/ml

1.60

116

(3045716) Anion gap in Serum or Plasma

290

1002

1.51

9.25

2.4

9.72

9.84

mmol/l

0.19

280

975

(3047007) Chlamydophila sp Ab [Presence] in Serum

935

3899

1.26

9.23

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

273

933

1.53

9.16

1.1

472.16

470.36

ng/l

0.00

227

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

187

583

1.68

9.13

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

185

576

1.68

9.08

1.1

—

(3028433) Virus identified in Specimen by Culture

243

812

1.56

9.02

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1622

7168

1.19

9.00

3.2

3.8

1.47

1.51

mg/l

1.32

1494

6643

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5249

25061

1.10

8.94

3.5

4.2

16.83

26.90

ug/l

1.87

4191

20058

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1008

4256

1.24

8.93

1.2

1.3

3.38

3.67

u/ml

0.21

344

1525

(3035947) Staphylolysin Ab [Units/volume] in Serum

340

1225

1.45

8.86

1.2

1.1

3.52

3.91

iu/ml

0.34

103

(3013247) Albumin in CSF/Albumin in Serum or Plasma

174

537

1.69

8.83

1.1

6.95

7.39

mg/g

0.27

167

508

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

398

1.81

8.81

1.2

1.4

94.46

296.17

ng/l

0.53

281

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

574

2261

1.33

8.80

2.8

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

956

4020

1.24

8.80

2.7

3.4

1.38

1.58

1.09

855

3580

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

174

538

1.69

8.78

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

142

414

1.79

8.76

1.5

1.4

5.71

6.81

nmol/l

0.55

133

400

(3012565) Volume of 24 hour Urine

343

1241

1.44

8.75

1.9

2.2

1988.53

1971.82

0.09

304

1115

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

374

1378

1.42

8.66

1.2

1.3

28.49

24.72

u/l

0.47

313

1207

(3002079) Sodium [Moles/time] in 24 hour Urine

316

1129

1.46

8.61

1.2

156.21

162.37

mmol/24h

0.65

316

1129

(3044927) Protein electrophoresis panel - Urine

561

2210

1.33

8.61

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

601

2392

1.31

8.59

2.7

3.4

56.17

56.95

0.38

510

2028

(3012494) Peanut IgE Ab [Units/volume] in Serum

232

779

1.56

8.47

1.1

5.55

20.98

u/ml

0.60

129

434

(40768800) Prostate Pathology biopsy report

821

5338

0.80

8.43

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

427

1.76

8.42

2.6

2.4

7.68

7.65

mmol/l

0.03

247

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

395

1478

1.40

8.40

1.5

1.6

6.00

7.11

u/l

0.89

298

1206

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

973

4125

1.23

8.34

1.2

3.84

3.94

u/ml

0.09

419

1905

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

121

341

1.85

8.33

1.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

524

2056

1.33

8.29

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

524

2056

1.33

8.29

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

524

2056

1.33

8.29

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

950

4020

1.24

8.29

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

950

4022

1.24

8.25

1.5

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

759

3137

1.27

8.15

1.2

62.41

51.19

u/ml

0.43

211

(3018851) Theophylline [Moles/volume] in Serum or Plasma

162

2.26

8.07

1.6

1.8

41.67

46.31

umol/l

0.58

162

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

241

826

1.52

8.06

1.2

111.06

111.01

0.01

219

738

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

293

1.91

8.04

1.0

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

381

1429

1.39

8.02

1.2

1.3

96.81

92.07

u/l

0.32

328

1263

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

361

1.81

7.99

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

373

1396

1.40

7.95

1.9

1.7

2.23

2.59

u/field

0.41

271

987

(21491868) Cryoglobulin [Mass/volume] in Serum

243

837

1.52

7.95

1.2

0.47

0.41

g/l

0.09

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

277

981

1.48

7.94

1.8

1.9

—

(3044941) Cell count panel - Synovial fluid

886

3740

1.24

7.93

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

300

1080

1.45

7.91

3.8

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1210

5277

1.20

7.85

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

258

904

1.49

7.80

1.2

0.31

0.30

g/l

0.30

210

715

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

801

3354

1.25

7.72

1.0

0.56

0.40

u/ml

0.42

226

827

(3051339) Copper [Moles/volume] in Blood

104

2.56

7.65

1.2

1.4

16.81

15.93

umol/l

0.57

(40761539) Cells [Type] in Urine sediment by Light microscopy

181

588

1.61

7.64

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

571

2298

1.30

7.59

1.5

1.6

30.81

30.97

0.03

340

1506

(3045683) HLA typing for celiac disease panel - Blood or Tissue

423

1630

1.36

7.58

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

137

414

1.73

7.57

1.4

1.6

0.22

nmol/l

0.01

111

312

(3000475) Leukocytes [#/volume] in Synovial fluid

1328

5862

1.19

7.55

1.6

1.7

14333.99

13768.75

e6/l

0.12

948

4328

(3034274) Bile acid [Moles/volume] in Serum --fasting

973

4172

1.22

7.54

1.9

2.2

5.64

7.08

umol/l

2.36

702

3093

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1313

5797

1.19

7.45

1.3

1.5

22.14

19.80

u/ml

0.21

111

(3010015) Selenium [Moles/volume] in Serum or Plasma

169

2.16

7.35

2.1

1.32

umol/l

0.03

151

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

719

2992

1.26

7.34

2.0

2.3

32.78

32.76

0.03

712

2968

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

156

494

1.65

7.29

1.5

1.6

0.40

0.41

ug/l

0.12

112

320

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

182

601

1.58

7.21

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1966

11684

0.87

7.19

1.9

—

(3004451) EKG impression Narrative

293

1071

1.43

7.18

1.2

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

166

537

1.61

7.16

1.2

424.19

293.82

pmol/l

0.64

112

397

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

107

306

1.83

7.11

1.3

46.07

55.03

0.86

150

(3033923) Metanephrine [Moles/time] in 24 hour Urine

138

426

1.69

7.10

1.1

0.66

4.09

umol/24h

0.50

208

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1318

5848

1.18

7.08

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

387

1488

1.36

7.07

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

421

1640

1.34

7.07

1.1

6.88

8.48

iu/ml

0.72

437

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

316

1176

1.40

7.03

2.2

2.1

102.92

84.21

ug/min

0.24

273

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

696

2905

1.25

6.96

1.1

96.77

95.53

0.58

655

2728

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

115

339

1.77

6.95

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

118

352

1.75

6.86

1.2

86.80

79.49

mmol/24h

—

(3045424) Erythrocytes [Presence] in Urine

999

4340

1.20

6.82

1.5

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

121

367

1.72

6.66

1.1

—

(3002619) Bacteria identified in Specimen by Culture

145

463

1.64

6.62

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

113

338

1.75

6.53

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

113

338

1.75

6.53

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1916

1.30

6.51

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

481

1935

1.30

6.50

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

244

1.88

6.47

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

480

1933

1.30

6.44

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

204

711

1.50

6.42

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

476

1917

1.30

6.39

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

249

1.87

6.38

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

475

1913

1.30

6.37

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

479

1932

1.30

6.36

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1847

8483

1.14

6.32

1.6

3.08

8.11

iu/ml

0.68

351

1819

(3033942) Copper [Moles/time] in 24 hour Urine

2.43

6.28

1.2

1.16

0.97

umol/24h

0.09

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

427

2889

0.77

6.28

1.6

8.06

7.58

mmol/l

3.81

407

2775

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

381

2614

0.76

6.23

1.4

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

228

819

1.45

6.20

1.1

95.30

88.75

1.43

104

397

(3001964) Herpes simplex virus Ag [Presence] in Specimen

216

769

1.47

6.15

1.4

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

828

3571

1.21

6.15

2.6

2.9

1418.40

677.08

u/ml

0.29

819

3525

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

239

868

1.44

6.15

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

232

838

1.45

6.14

1.1

93.15

89.19

1.03

101

405

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1205

5384

1.17

6.03

1.3

1.5

106.46

112.59

u/ml

1.26

248

1179

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

228

1.88

6.01

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

236

859

1.44

6.01

5.4

6.3

24.94

25.00

mmol/l

0.08

221

773

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

400

1588

1.32

5.99

3.0

3.5

105.32

141.58

nmol/l

1.75

393

1565

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

121

379

1.67

5.99

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1449

6574

1.15

5.94

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

424

1702

1.30

5.87

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

253

1.82

5.84

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

649

2749

1.23

5.78

1.4

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

649

2749

1.23

5.78

1.4

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

233

856

1.42

5.67

1.1

1.2

112.96

105.82

1.77

209

773

(3000093) Morphology [Interpretation] in Blood Narrative

584

2453

1.24

5.63

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

559

2340

1.25

5.56

3.9

5.1

55.51

128.18

u/ml

3.82

154

805

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.79

5.53

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

266

1.77

5.49

2.6

3.4

40.20

43.62

umol/l

0.74

219

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

123

2.17

5.48

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

388

1555

1.30

5.48

1.9

2.3

99.60

96.06

1.11

358

1452

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

318

1239

1.34

5.46

1.1

78.39

86.18

u/l

1.04

282

1130

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

155

2.02

5.44

1.4

1.5

40.05

35.69

0.28

104

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

262

991

1.38

5.42

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

711

3062

1.21

5.42

1.1

1.36

2.18

iu/ml

1.59

(3034891) Synovial lining cells/100 cells in Synovial fluid

300

1166

1.34

5.26

1.5

4.16

4.43

0.09

299

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

316

1240

1.33

5.20

1.1

20.37

25.94

u/l

1.19

280

1127

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

263

1.75

5.20

2.0

1.9

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

660

2835

1.22

5.19

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1273

5784

1.15

5.18

3.9

3.0

27.27

27.22

mg/l

0.02

775

3700

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

203

1484

0.71

5.17

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

462

1910

1.26

5.15

2.6

2.5

747.71

657.29

e6/l

1.88

438

1861

(3011412) CD3 cells [#/volume] in Blood

599

2550

1.23

5.15

2.4

1.27

1.18

e9/l

0.96

518

2294

(3019897) Erythrocyte distribution width [Ratio] by Automated count

680

4267

0.83

5.11

3.3

2.2

13.16

13.11

0.70

673

4209

(37021550) Renin [Units/volume] in Plasma --upright

141

479

1.54

5.10

1.3

92.02

68.50

mu/l

0.53

362

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

135

2.05

5.01

1.4

1.5

14.58

12.59

0.20

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

220

1.80

5.00

2.2

2.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.06

4.98

1.7

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

487

2036

1.25

4.95

2.2

1.9

1.98

2.28

u/field

0.57

238

863

(3000330) Specific gravity of Urine by Test strip

2662

12679

1.10

4.89

3.6

3.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

199

1.84

4.88

1.5

1.6

2.46

1.57

mg/l

0.66

126

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

308

1.66

4.88

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

203

1.83

4.87

1.1

—

(40757373) Influenza virus identified in Isolate

137

469

1.53

4.81

1.5

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

890

3961

1.18

4.78

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

971

4352

1.17

4.78

1.2

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.76

1.0

0.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

117

2.10

4.73

1.3

1.4

1.65

1.82

0.06

(3003129) Base excess in Capillary blood by calculation

159

565

1.47

4.69

1.6

0.76

0.22

mmol/l

0.87

153

532

(3027456) Digoxin [Moles/volume] in Serum or Plasma

943

4231

1.17

4.60

3.3

3.0

0.80

0.81

nmol/l

0.10

692

3269

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

406

1680

1.26

4.55

1.2

1.07

ratio

0.16

147

581

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

299

1.64

4.51

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

656

2860

1.20

4.49

1.6

27.46

34.13

iu/ml

0.63

129

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

1.00

0.74

mg/l

0.34

124

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

1.87

1.44

mg/l

0.27

113

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

3.56

4.56

mg/l

0.53

123

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

1.96

3.03

mg/l

0.81

143

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

2.53

2.05

mg/l

0.34

132

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

2.51

1.70

mg/l

0.44

116

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

1.82

1.74

mg/l

0.06

139

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

2.66

1.99

mg/l

0.39

139

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

194

1.80

4.45

1.5

1.6

1.62

2.04

mg/l

0.26

130

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

639

2782

1.20

4.45

3.1

3.3

6.03

8.10

nmol/l

0.46

617

2705

(21494815) CD4 cells/100 lymphocytes in Specimen

543

2328

1.22

4.43

2.3

2.1

39.73

37.80

2.29

529

2285

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1252

5750

1.14

4.43

1.5

1.4

119.44

126.69

pmol/l

0.21

1219

5609

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

132

1.98

4.35

1.2

1.1

1.09

1.21

u/field

0.47

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

314

1266

1.30

4.35

1.1

1.2

11.13

11.72

u/ml

0.03

137

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

271

1.66

4.29

2.0

2.7

0.92

1.47

mmol/l

1.34

194

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

138

487

1.48

4.26

1.1

3.34

7.74

u/ml

0.81

346

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

706

3117

1.18

4.23

1.5

1.6

58.11

56.75

0.37

434

2082

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1902

8982

1.11

4.21

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

621

2712

1.20

4.21

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.56

4.20

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

123

2.00

4.20

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

109

367

1.55

4.18

1.7

35.41

50.69

pmol/l

1.21

303

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

149

1.89

4.17

1.0

20.64

20.17

u/ml

0.02

126

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

437

1844

1.24

4.17

2.4

2.5

538.39

531.51

e6/l

0.08

346

1560

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

300

1210

1.30

4.16

1.0

1.1

99.69

96.40

0.94

238

971

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

302

1223

1.29

4.07

1.8

2.0

135.18

143.05

1.07

278

1150

(3011841) English Walnut IgE Ab [Units/volume] in Serum

256

1.65

4.02

1.0

1.42

1.16

u/ml

0.07

193

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

249

985

1.32

3.99

1.8

2.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

285

1.61

3.98

1.0

0.22

0.26

u/ml

0.15

178

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

249

986

1.32

3.97

1.8

2.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

631

2777

1.19

3.95

2.3

2.6

1.16

1.35

g/24h

1.07

296

1454

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

179

1.78

3.93

1.0

0.18

1.13

u/ml

0.97

121

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1338

6227

1.12

3.89

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

252

1003

1.31

3.89

1.8

2.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

148

541

1.43

3.86

1.1

1.0

0.79

2.72

u/ml

0.90

125

465

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

228

1.67

3.81

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

238

943

1.32

3.80

2.4

2.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

229

903

1.32

3.78

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

178

1.76

3.75

1.2

16.22

14.83

nmol/l

0.17

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.36

3.73

1.0

—

(3010503) CD19 cells [#/volume] in Blood

370

1555

1.24

3.72

2.7

2.5

0.21

0.37

e9/l

1.09

352

1525

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

923

4208

1.15

3.72

2.4

3.1

675.16

4748.39

u/ml

1.05

254

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

160

1.79

3.67

1.0

0.56

2.59

u/ml

1.27

128

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

207

1.69

3.65

1.2

1.1

1.64

3.50

umol/24h

0.54

207

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

541

1.41

3.57

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

386

1.49

3.56

1.2

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

158

1.78

3.55

1.1

1.29

3.20

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1204

5607

1.12

3.50

4.5

6.0

1041.20

1192.23

iu/ml

0.12

122

880

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

219

870

1.31

3.47

1.1

1.0

12.45

12.23

u/ml

0.04

113

518

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

183

1.71

3.45

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

302

1256

1.26

3.37

1.1

1624.87

1486.23

miu/ml

1.24

302

1256

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

418

1801

1.21

3.36

2.5

0.23

e9/l

0.09

345

1561

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

287

1.55

3.31

1.7

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

468

2044

1.20

3.28

2.1

73.84

72.33

1.46

442

1977

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

308

1289

1.25

3.27

1.7

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

434

1883

1.20

3.26

2.2

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

308

1290

1.25

3.25

1.7

1.9

—

(3016750) Collection duration of Urine

350

1488

1.23

3.23

2.1

2.2

516.27

496.67

min

3.43

256

1138

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

140

1.79

3.22

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

150

570

1.37

3.21

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

150

570

1.37

3.21

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

150

570

1.37

3.21

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

150

570

1.37

3.21

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

408

1765

1.21

3.18

1.0

1.1

2.63

2.58

u/ml

0.01

111

427

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

192

1.66

3.16

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

413

1790

1.21

3.15

1.1

3.07

2.94

u/ml

0.03

146

562

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

215

865

1.30

3.15

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

556

2476

1.17

3.13

2.0

2.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

169

1.70

3.11

1.3

1.2

18.33

25.29

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

280

1.53

3.07

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

791

3623

1.14

3.06

3.8

3.4

32.04

39.70

u/ml

1.12

768

3487

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

264

1.54

3.04

1.0

0.11

2.16

u/ml

1.52

197

(40761995) Spermatozoa Progressive [#/volume] in Semen

135

957

0.74

3.02

2.9

3.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

1.72

3.01

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

135

956

0.74

3.01

5.9

6.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

175

1.67

3.00

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

666

3020

1.15

2.98

2.6

2.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.21

2.96

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

223

914

1.27

2.87

1.9

2.1

159.83

168.42

0.50

209

866

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.54

2.83

1.5

3.4

3.05

2.54

mu/l

0.14

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

416

1826

1.19

2.82

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

519

2323

1.17

2.79

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

252

1054

1.25

2.76

2.8

2.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

170

677

1.31

2.74

1.6

9.15

9.05

ug/l

0.10

170

677

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

106

766

0.72

2.73

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

119

449

1.38

2.72

2.5

2.7

36.91

61.67

mg/l

0.71

(3002621) Streptococcal DNAse B [Units/volume] in Serum

242

1.53

2.72

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

175

701

1.30

2.71

1.3

1.2

38.33

40.88

g/l

1.34

386

(40768441) Liver Pathology biopsy report

422

1863

1.18

2.70

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

259

1090

1.24

2.70

6.5

11.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

311

1.46

2.67

2.7

2.3

0.59

0.52

u/field

0.31

311

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

165

1.65

2.67

1.1

8.56

11.67

u/l

0.77

165

(3030313) Adrenal Ab [Titer] in Serum

239

1.53

2.67

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

256

1.51

2.66

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

283

1205

1.23

2.65

1.1

1.2

—

(3024263) Appearance of Synovial fluid

297

1271

1.22

2.65

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

219

1.55

2.63

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.06

2.63

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

174

1.62

2.62

1.0

1.1

0.70

0.51

u/ml

0.19

106

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

150

1.67

2.61

1.2

1.4

23.68

21.92

mmol/l

1.29

102

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.01

2.59

1.0

228.93

212.16

pmol/l

0.06

(40768793) Breast Pathology biopsy report

1101

5202

1.11

2.58

1.3

—

(1761868) Lipid panel - Serum or Plasma

19409

103326

0.97

2.56

2.8

2.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

151

1.66

2.56

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

348

1519

1.20

2.55

2.7

2.8

40.05

38.60

0.69

189

823

(3013166) Neutrophils/100 leukocytes in Synovial fluid

180

731

1.29

2.54

1.3

1.4

52.01

57.02

0.99

155

628

(3020393) Adenovirus Ag [Presence] in Stool

276

1.48

2.54

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

100

373

1.40

2.48

2.9

3.0

14.79

14.75

ml/dl

0.04

348

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1049

4957

1.11

2.47

2.9

3.4

610.32

968.06

u/ml

0.55

929

4517

(3000060) B lymphocytes [#/volume] in Blood

187

767

1.27

2.46

2.0

2.1

2187.14

506.30

e6/l

0.59

419

(3008037) Lactate [Moles/volume] in Venous blood

1151

5467

1.10

2.45

3.7

3.0

1.61

1.57

mmol/l

0.50

1135

5361

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

140

553

1.32

2.44

1.1

1.2

85.58

89.18

0.39

169

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

452

2028

1.16

2.42

2.1

2.0

14.07

15.30

1.91

436

1976

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

134

527

1.33

2.41

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

819

3826

1.12

2.40

1.2

—

(3024471) HLA-A [Type]

153

1024

0.78

2.35

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

147

1.63

2.34

1.5

1.2

28.72

15.22

pmol/l

0.97

127

(3052592) Norovirus Ag [Presence] in Stool

120

468

1.34

2.30

1.2

1.4

—

(3036603) Volume of Urine

390

1738

1.17

2.29

1.4

1.6

2025.81

1932.23

1.09

382

1684

(3010144) Erythrocytes [#/volume] in Synovial fluid

512

2330

1.15

2.28

1.3

1.4

162753.40

93615.53

e6/l

1.07

365

1566

(3020123) Porphyrins [Interpretation] in Serum or Plasma

136

1.65

2.28

1.3

1.0

—

(3004775) Volume in Urine collected for unspecified duration

451

2035

1.16

2.27

2.2

2.3

695.05

674.62

0.43

319

1411

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.90

2.26

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.24

1.2

85.23

62.37

e6/l

0.16

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

267

1.45

2.23

3.3

3.0

1.28

1.38

mg/l

0.16

178

(3002523) Influenza virus A Ag [Presence] in Specimen

1005

4770

1.10

2.21

1.1

—

(3024932) HLA-DR beta [Type]

151

1003

0.79

2.20

1.1

—

(3012898) Urea [Moles/volume] in Urine

256

1.45

2.16

1.8

1.4

178.79

166.70

mmol/l

0.33

228

(3042733) HLA Ab [Presence] in Serum

158

1041

0.79

2.16

4.7

5.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1004

4772

1.10

2.16

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

277

1207

1.20

2.14

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1084

6178

0.91

2.13

1.8

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

137

553

1.29

2.10

1.1

1.2

74.71

76.99

0.17

163

(3027035) Albumin [Mass/time] in 24 hour Urine

224

1.47

2.07

1.3

305.92

405.05

mg/24h

—

(4212803) Bone marrow aspirate examination

199

1.50

2.04

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

351

0.65

2.04

8.0

8.7

0.31

0.34

umol/l

0.26

314

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

599

2779

1.13

2.04

1.3

1.4

8.99

7.95

mmol/l

5.88

568

2692

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

174

1.53

2.03

2.6

3.0

43.47

410.11

pmol/l

0.51

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.86

2.00

1.0

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.07

1.99

1.0

3.37

0.45

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

287

1.40

1.99

1.0

0.35

0.78

u/ml

0.48

152

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

102

399

1.33

1.97

1.1

1.30

7.94

pmol/l

—

(3006245) CD3-CD19+ cells/100 cells in Blood

242

1053

1.20

1.93

2.0

2.2

9.73

11.31

1.30

224

979

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

190

807

1.23

1.93

3.1

3.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

232

1.44

1.93

1.2

1.3

5.92

6.63

mmol/l

0.42

119

(3019768) Coxiella burnetii Ab [Presence] in Serum

148

1.55

1.88

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

496

2291

1.13

1.85

3.0

35.75

60.27

mg/l

1.98

373

1638

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

336

1.35

1.84

2.5

2.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

292

1.38

1.83

1.0

4.57

2.85

u/ml

0.15

152

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

125

510

1.28

1.81

5.0

6.2

67.35

71.65

0.92

412

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.06

1.80

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

271

1202

1.18

1.78

1.4

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

105

420

1.31

1.77

1.1

1.4

137.00

144.30

titre

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.68

1.77

1.0

1.1

2.12

0.95

u/field

0.54

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

134

1.56

1.76

1.1

58.46

49.58

u/l

0.34

105

(3027974) Hepatitis B virus e Ag [Presence] in Serum

151

1.52

1.75

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1794

8812

1.06

1.74

3.1

3.6

985.03

1532.35

u/ml

0.53

1531

7607

(3016228) CD19 cells/100 cells in Blood

236

1038

1.19

1.72

2.2

2.0

8.90

8.24

0.37

226

1022

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

805

1.21

1.71

2.2

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

270

1202

1.17

1.71

1.4

1.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

287

1.36

1.71

1.2

1.4

25.05

24.21

0.07

222

(3015076) Soybean IgE Ab [Units/volume] in Serum

355

1616

1.15

1.68

1.0

0.66

1.08

u/ml

0.44

106

386

(40763480) Human metapneumovirus Ag [Presence] in Specimen

115

1.59

1.68

1.3

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

202

0.59

1.67

2.3

2.9

33.11

10.79

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.63

1.66

1.3

1.16

1.12

u/field

0.08

(3022229) Phosphate [Moles/volume] in Urine

175

0.57

1.65

1.3

2.2

21.06

20.09

mmol/l

0.08

148

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

325

1.33

1.64

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

316

1.34

1.64

1.2

1.3

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.86

1.64

1.1

0.05

0.04

g/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

136

569

1.25

1.64

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

243

1077

1.18

1.64

1.7

1.9

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.04

1.63

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

299

1.34

1.62

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

206

1.42

1.61

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.65

1.60

1.1

966.83

342.96

u/l

0.62

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.70

1.60

1.1

1.2

1779.81

4878.12

ng/l

1.23

(3038515) Glucose [Moles/volume] in Venous blood

1072

5194

1.08

1.58

3.8

3.1

7.55

mmol/l

0.00

1056

5107

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

383

1763

1.13

1.56

1.4

12.54

12.91

u/l

0.44

369

1708

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

204

895

1.19

1.56

1.9

1.6

63840.16

17464.97

u/ml

0.50

110

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

234

1040

1.17

1.54

1.9

2.1

28.26

29.52

0.72

219

987

(3024316) Viscosity of Plasma

122

1.54

1.3

1.9

1.76

1.65

mpas

0.24

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

403

1.28

1.51

4.7

4.8

44.48

45.05

ug/min

0.03

319

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

330

1.31

1.51

2.6

87.43

70.40

pmol/l

0.23

288

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

388

1793

1.13

1.50

1.7

1.6

—

(3017704) Immunofixation for Urine

283

1280

1.15

1.50

1.4

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

367

1.29

1.50

1.6

1.4

215720.58

212711.22

nmol/l

0.01

307

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

332

1522

1.14

1.46

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

145

1.48

1.46

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

824

3967

1.09

1.45

1.5

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

251

1.35

1.44

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

277

1256

1.15

1.44

3.2

2.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.80

1.44

5.8

5.4

0.23

0.25

mmol/l

0.10

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

365

1.29

1.43

1.1

1.3

33.67

44.25

mg/l

1.50

309

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

631

3006

1.10

1.42

1.9

24.87

23.72

ug/l

0.14

619

2948

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

241

1083

1.16

1.41

2.5

2.7

160.69

135.14

au/ml

0.27

135

(3022493) Free Hemoglobin [Mass/volume] in Plasma

253

1142

1.16

1.40

4.0

5.8

910.93

3165.05

mg/l

1.36

172

814

(3007916) DNA double strand Ab [Titer] in Serum

316

1.31

1.40

1.3

166.67

121.04

titre

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

147

1.46

1.38

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

228

1023

1.16

1.37

2.2

2.0

—

(3003694) ABO and Rh group [Type] in Blood

15585

82599

0.98

1.34

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

287

1314

1.14

1.32

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

113

477

1.24

1.32

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

356

1.28

1.32

1.0

0.02

0.21

u/ml

0.98

229

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

841

4072

1.08

1.32

1.3

1.4

7.24

7.01

mmol/l

1.28

746

3600

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.74

1.30

1.1

1.0

0.31

0.68

u/ml

0.66

(21494567) Legionella sp IgM Ab [Presence] in Serum

171

1.40

1.30

1.1

—

(40768806) Pleura Pathology biopsy report

521

2478

1.10

1.25

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.17

1.22

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

297

1372

1.13

1.22

7.7

5.6

439.49

4333.43

u/ml

0.87

251

(3019174) dRVVT (LA screen)

250

1.32

1.22

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

549

0.80

1.21

5.0

5.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

156

1.41

1.21

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

197

885

1.16

1.21

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

100

1.51

1.20

1.6

0.00

0.17

u/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.64

1.19

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

160

980

0.85

1.18

1.7

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

408

1924

1.11

1.18

1.8

3.74

3.91

mg/l

0.29

377

1845

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

254

1165

1.14

1.18

2.1

2.3

22.01

257.27

ug/l

1.81

237

1117

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

247

1.31

1.17

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

394

0.77

1.16

2.4

1.3

7.21

7.23

mmol/l

0.02

132

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

101

1.50

1.16

1.3

1.5

—

(4035726) Immunohistochemistry procedure

4415

22389

1.03

1.14

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

133

582

1.19

1.13

1.1

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.61

1.13

1.0

0.10

0.09

u/ml

0.05

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

262

1209

1.13

1.12

2.9

3.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

181

1.36

1.12

1.3

1.2

—

(3034426) Prothrombin time (PT)

206

937

1.15

1.10

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

151

1.38

1.08

1.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

160

1.37

1.08

1.6

1.8

1.68

0.54

1.23

122

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

256

1184

1.13

1.07

3.1

3.3

7.98

7.89

mg/l

0.07

194

964

(3017461) Flecainide [Moles/volume] in Serum or Plasma

138

1.40

1.07

1.4

1.8

0.80

0.66

umol/l

0.62

105

(40759632) Porphyrins [Mass/mass] in Stool

2.04

1.06

1.4

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.53

1.06

1.0

1.1

220.10

273.78

nmol/l

0.93

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.67

1.06

1.2

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

197

1.32

1.05

1.1

17.07

34.62

u/ml

1.53

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

197

1.32

1.05

1.1

28.67

25.01

u/ml

—

(3012441) Differential panel - Pleural fluid

514

2469

1.09

1.04

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

392

1.23

1.04

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

117

1.43

1.03

1.2

1.3

12.42

23.42

u/ml

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.15

1.03

1.4

2.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

148

1.38

1.03

1.5

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

142

632

1.17

1.02

1.2

1657.14

283.64

titre

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

144

1.38

1.02

1.2

1.3

2059.17

939.12

u/l

0.32

131

(3032743) Legionella sp IgG Ab [Presence] in Serum

167

1.34

1.00

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

586

3294

0.93

1.00

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.67

0.99

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

190

868

1.14

0.98

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

223

1312

0.89

0.98

27.6

28.0

125.61

114.53

ug/l

0.65

183

1109

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

274

1.26

0.96

1.0

0.91

0.46

u/ml

0.38

153

(3021162) Amylase [Enzymatic activity/volume] in Specimen

387

1.21

0.96

2.8

1688.52

1635.79

u/l

0.02

348

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.93

0.95

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

105

460

1.19

0.93

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

147

1.35

0.92

1.7

198.34

181.49

ug/g

0.23

129

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

211

1238

0.89

0.91

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

159

723

1.15

0.90

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

208

1220

0.89

1.2

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

1.58

0.89

1.4

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

130

1.37

0.89

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

254

1.25

0.88

1.6

2.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

582

0.84

0.86

1.4

23.38

21.86

0.19

476

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

248

0.76

0.86

2.5

4.5

2.38

2.39

mg/l

0.01

212

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

149

1.33

0.86

1.0

1.3

—

438.57

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

0.65

0.84

1.2

1.0

—

(3001729) Color of Synovial fluid

191

1.28

0.84

1.6

1.7

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

124

558

1.16

0.83

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

186

862

1.13

0.82

2.4

1.9

3150.54

3414.80

e6/l

0.03

121

598

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

124

559

1.16

0.81

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

314

1791

0.91

0.81

1.4

29.86

32.47

nmol/l

0.85

281

1676

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.62

0.81

1.1

2.14

2.89

0.66

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

197

917

1.12

0.81

1.2

—

(3033799) Differential panel - Peritoneal fluid

162

745

1.14

0.81

2.2

1.9

—

(3015183) Erythrocyte sedimentation rate

304

1449

1.10

0.80

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

124

560

1.16

0.80

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

329

1.21

0.80

1.1

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

143

0.69

0.79

1.6

1.3

1.82

1.67

mg/l

0.16

118

(3013293) Extractable nuclear Ab [Presence] in Serum

377

1.19

0.79

1.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.81

0.79

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

185

0.73

0.79

1.0

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

226

1.25

0.78

1.1

1.0

6.22

4.00

u/ml

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

442

2145

1.08

0.77

3.9

3.7

48.11

52.91

u/ml

0.17

437

2115

(3044007) Cell count panel - Peritoneal fluid

151

695

1.13

0.76

2.3

1.8

—

(3007147) Virus identified in Stool by Electron microscopy

2.17

0.76

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.68

0.75

3.4

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

396

1917

1.08

0.74

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.65

0.74

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13438

69352

1.01

0.74

4.1

21.64

22.05

2.08

5722

32925

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

181

1.27

0.74

3.9

4.8

—

(3027874) Urate [Moles/volume] in Urine

1.42

0.73

1.0

1.1

1.88

9.01

mmol/l

0.49

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

305

0.80

0.73

1.4

76.14

70.82

0.57

248

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

210

1.24

0.71

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

182

1.26

0.71

1.0

1.1

8.85

8.32

u/ml

0.05

125

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.55

0.70

2.1

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6181

31719

1.02

0.69

1.5

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

175

1016

0.90

0.69

2.6

3.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

154

716

1.12

0.68

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

186

876

1.11

0.66

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

586

1.13

0.65

2.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

362

1.17

0.64

1.3

1.4

9.12

12.40

0.63

178

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

332

1613

1.07

0.61

1.4

5.85

5.52

mmol/l

3.71

310

1539

(3038071) Oxygen [Partial pressure] in Mixed venous blood

583

0.88

0.60

6.7

8.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

113

666

0.89

0.60

7.0

8.2

—

(3022670) pH of Venous cord blood

1.51

0.59

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

542

1.13

0.58

1.6

1.3

23.37

36.87

g/l

0.70

435

(3011544) Albumin [Mass/volume] in Pleural fluid

221

1.20

0.58

1.2

1.1

18.13

17.27

g/l

0.28

206

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

245

1384

0.92

0.57

1.2

1.3

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.38

0.57

1.5

1.7

141.10

118.43

ug/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

161

761

1.10

0.57

2.4

1.8

10988.22

14075.20

e6/l

0.23

407

(3044009) aPTT.lupus sensitive (LA screen)

265

1.18

0.56

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.55

0.56

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

416

1.14

0.56

1.2

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.34

0.55

1.0

1.1

0.20

0.21

g/l

0.28

(3032868) Hemoglobin electrophoresis panel in Blood

277

0.83

0.55

1.4

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.38

0.55

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

322

0.84

0.55

1.3

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

189

0.80

0.51

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

234

1.18

0.51

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

114

663

0.90

0.51

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

496

0.88

0.49

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

440

0.88

0.48

6.4

6.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.46

0.48

1.0

1.1

69.13

66.33

0.21

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

107

1.27

0.48

1.0

0.07

0.15

u/ml

0.40

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.58

0.48

6.0

4.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

642

3495

0.96

0.48

2.4

2.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.46

0.47

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

131

751

0.91

0.46

1.3

3.68

3.40

mmol/l

0.42

114

694

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

108

1.26

0.45

11.2

8.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

503

1.11

0.45

1.2

0.71

46.54

mg/l

1.98

360

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

355

1.13

0.45

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

111

640

0.91

0.45

2.5

110.90

109.65

ng/l

0.03

368

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.49

0.44

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

457

2274

1.05

0.44

1.3

6.45

6.23

mmol/l

0.78

418

2112

(3007919) Fasciola sp Ab [Titer] in Serum

1.42

0.44

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.75

0.44

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.63

0.44

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

219

1.17

0.43

1.1

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.43

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.43

0.0

5.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

138

660

1.09

0.43

1.2

1.3

406.00

224.92

ug/l

0.42

357

(3026692) Albumin [Mass/volume] in Peritoneal fluid

130

620

1.09

0.43

1.5

1.3

12.35

13.86

g/l

0.97

475

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

115

0.77

0.42

7.2

13.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

211

1178

0.93

0.41

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

149

0.81

0.41

3.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

146

702

1.09

0.41

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

314

1.13

0.40

3.0

—

(36303858) Crystals [Presence] in Urine

1.42

0.40

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

243

1348

0.94

0.40

34.5

36.3

7.18

7.34

ug/l

0.63

222

1221

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9561

50342

0.99

0.40

2.9

0.66

0.79

ug/l

27.26

6296

32029

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

192

1.17

0.40

1.2

103.60

107.80

ug/l

0.06

121

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

321

1589

1.05

0.39

5.8

6.8

—

(3034614) HLA Ag [Interpretation]

1.33

0.39

1.5

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

338

1678

1.05

0.38

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

198

1.16

0.37

1.0

1.1

12.33

20.78

iu/ml

0.43

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.27

0.37

1.1

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.30

0.37

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.30

0.37

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.30

0.37

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.30

0.37

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.30

0.37

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.30

0.37

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

124

0.80

0.37

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

170

827

1.07

0.37

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

1.49

0.37

1.0

1.4

327.17

284.57

nmol/l

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.36

0.34

1.2

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.65

0.34

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.37

0.34

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

226

1116

1.06

0.33

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.41

0.32

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

206

1.14

0.32

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.24

0.32

1.1

1.0

0.10

0.09

u/ml

0.03

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.30

0.31

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

247

1.12

0.30

1.1

23.57

19.59

u/l

0.75

162

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.26

0.30

1.6

1.0

—

(3013862) HLA-DP [Type]

103

0.81

0.29

1.0

—

(46236302) HLA-C [Type] by High resolution typing

103

0.81

0.29

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

158

776

1.06

0.29

2.3

1.6

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

114

0.82

0.29

1.1

1.0

0.36

0.22

u/ml

0.29

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.73

0.28

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

108

0.82

0.28

1.1

1.0

0.23

0.45

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

429

1.08

0.27

1.1

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

219

1.12

0.27

1.3

1.22

1.56

ml/s/173m2

0.37

133

(37019676) Renin [Units/volume] in Plasma --supine

1.30

0.27

1.0

1.1

18.32

68.49

mu/l

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.24

0.26

1.0

1.1

1154.44

2324.74

titre

—

(3016135) IgD [Mass/volume] in Serum

1.23

0.26

2.6

1.8

80.13

113.93

mg/l

0.27

(3004446) Plasmodium sp identified in Blood by Light microscopy

300

1.10

0.26

2.7

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.18

0.26

1.0

0.11

0.04

u/ml

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

118

0.84

0.25

2.1

2.9

—

(40760410) HLA-B [Type] by High resolution

101

0.83

0.25

1.0

—

(40763590) HLA-DQ beta [Type]

101

0.83

0.25

1.0

—

(40760409) HLA-A [Type] by High resolution

101

0.83

0.25

1.0

—

(3013762) Body weight Measured

107

1.17

0.25

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

123

0.85

0.24

2.1

3.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

148

731

1.06

0.24

1.4

3.20

2.67

0.31

124

611

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

420

2124

1.03

0.24

1.6

1.7

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.37

0.24

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

392

1.08

0.24

1.5

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

289

1453

1.04

0.23

1.9

2.0

3.37

3.79

ug/l

0.31

261

1336

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.30

0.23

2.2

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.28

0.23

1.1

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

123

1.15

0.22

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

153.14

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.22

0.0

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

356

1917

0.97

0.22

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

114

1.14

0.21

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1283

6597

1.02

0.20

4.8

3.7

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.17

0.20

1.0

0.04

0.19

u/ml

—

(3035880) pH of Pleural fluid

243

1314

0.97

0.20

1.2

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

431

2193

1.03

0.19

1.3

604.76

455.56

u/l

0.60

406

2082

(3026726) Creatinine [Moles/volume] in Specimen

229

0.91

0.19

2.1

2.6

560.15

343.20

umol/l

0.23

220

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.84

0.19

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.20

0.19

3.4

5.3

—

(3048879) Bone marrow aspiration report

146

729

1.05

0.18

1.7

1.9

—

(3003157) Bacteria [#/volume] in Mother's milk

0.82

0.18

10.1

6.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

631

3229

1.02

0.18

1.4

1.5

33.56

32.94

g/l

0.56

566

2910

(4281824) Cell count and differential, peritoneal fluid

502

2679

0.98

0.18

1.1

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.24

0.18

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

297

1.07

0.17

1.9

1.7

1.76

1.72

mg/l

0.08

248

(3027570) Oxalate [Moles/time] in 24 hour Urine

168

0.90

0.17

1.5

1.3

295.00

313.37

umol/24h

0.27

168

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.83

0.17

7.4

8.8

—

(3006598) pH of Arterial cord blood

1.20

0.17

1.0

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

308

0.93

0.17

1.3

1.2

46.66

302.83

u/l

0.98

215

(3009883) Potato IgE Ab [Units/volume] in Serum

1.13

0.16

1.0

0.37

0.45

u/ml

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.78

0.15

2.4

2.9

34.13

38.76

umol/l

—

(40765096) Chromosome analysis panel by Banding

133

722

0.96

0.15

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

341

1822

0.98

0.15

1.8

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.86

0.15

3.8

3.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

148

1.09

0.14

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

443

1.05

0.14

4.6

5.7

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.15

0.14

3.1

6.0

5.84

7.78

mg/l

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

219

1.07

0.14

2.3

49.39

61.74

1.26

135

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

113

1.11

0.14

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

330

1761

0.98

0.13

1.2

1.3

16.55

13.90

u/l

0.86

308

1623

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

203

0.93

0.13

3.0

2.4

—

(3018133) Calcium [Moles/volume] in Urine

459

0.96

0.13

1.6

2.2

2.42

2.69

mmol/l

0.53

413

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

201

1020

1.03

0.13

2.2

2.0

8.37

9.52

mg/l

1.98

156

817

(3014891) Appearance of Pleural fluid

331

0.95

0.13

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

384

0.95

0.13

2.1

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

143

0.91

0.12

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

278

1419

1.02

0.12

2.0

2.1

2.41

2.31

ug/l

0.11

229

1196

(3045142) Bone marrow Pathology biopsy report

538

2765

1.02

0.12

1.3

—

(3018291) Platelet Ab [Presence] in Serum

1.17

0.12

1.1

—

(21494434) Karyotype in Bone marrow

416

2134

1.02

0.12

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

482

0.96

0.10

1.9

1.7

1.93

4.05

ug/l

1.17

301

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

397

0.96

0.10

1.1

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.09

0.10

1.0

3.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

164

835

1.03

0.09

1.4

63.17

62.68

0.06

137

681

(3032641) Amino acids panel - Urine

1.12

0.09

1.0

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.82

0.08

1.0

1.3

—

(40762814) Titanium [Mass/volume] in Blood

416

0.97

0.08

2.3

3.93

3.84

ug/l

0.04

142

(3001218) Citrate [Mass/time] in 24 hour Urine

1.07

0.08

1.7

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

129

657

1.02

0.08

1.3

39.60

38.38

0.13

451

(43055442) Apixaban [Mass/volume] in Serum or Plasma

296

1.04

0.08

1.4

1.6

122.06

113.19

ug/l

0.25

243

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

173

1.06

0.07

2.5

2.3

17.89

15.92

0.13

(3008607) Semen analysis panel

271

1.04

0.07

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

100

509

1.03

0.06

1.8

2.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

138

1.06

0.06

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

440

0.97

0.06

1.2

1.50

1.68

mmol/l

0.77

273

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

170

0.95

0.06

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

154

0.95

0.06

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

118

1.06

0.06

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

190

1.04

0.06

2.4

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

154

1.05

0.06

1.6

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

135

692

1.02

0.05

1.9

2.0

23.44

39.27

u/l

1.44

121

632

(3013336) Amino acids [Identifier] in Serum or Plasma

0.90

0.05

1.9

2.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

180

0.96

0.05

2.1

2.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

155

822

0.98

0.05

1.9

1.7

79.70

136.95

au/ml

1.09

(3042010) Triglyceride [Moles/volume] in Pleural fluid

354

0.97

0.05

1.2

0.72

1.45

mmol/l

1.00

222

(40768446) Kidney Pathology biopsy report

228

1176

1.01

0.05

1.6

1.7

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

116

0.94

0.04

1.1

1.2

0.07

g/l

0.34

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

191

1.04

0.04

4.9

5.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.11

0.04

1.0

1.3

0.80

0.65

u/field

—

(3022475) Manganese [Moles/volume] in Blood

155

1.04

0.04

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

486

2554

0.99

0.04

1.2

—

(3000285) Sodium [Moles/volume] in Blood

310

0.98

0.03

1.2

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

130

1.04

0.03

1.0

1.15

11.65

u/ml

0.45

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.92

0.03

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

136

0.96

0.03

10.9

10.5

114.15

239.80

e6/l

0.86

104

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

385

1.02

0.02

2.6

2.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.95

0.02

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

856

4456

1.00

0.02

1.3

3.29

3.91

ug/l

1.64

780

4039

(3007542) Rye IgE Ab [Units/volume] in Serum

147

1.03

0.01

1.0

0.29

13.40

u/ml

0.51

(3020356) Listeria sp identified in Specimen by Organism specific culture

199

1.02

0.01

1.2

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.93

0.01

2.0

1.4

1.73

2.03

mmol/24h

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

506

2635

1.00

0.01

1.5

88139.33

51348.63

e6/l

0.84

310

1584

(3000919) Neutrophils/100 leukocytes in Pleural fluid

127

659

1.01

0.00

1.4

26.25

20.31

1.42

113

590

(3018001) Oat IgE Ab [Units/volume] in Serum

195

1.02

0.00

1.1

1.0

0.26

0.93

u/ml

0.68

118

(40765089) Chromosome analysis panel - Blood by G-banded

206

1072

1.00

0.00

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.99

0.00

1.1

1.0

—

(3003577) Lead [Moles/volume] in Blood

225

1.00

0.00

1.4

1.5

0.17

0.20

umol/l

0.46

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

253

0.99

0.00

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

143

0.99

0.00

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

102

0.97

0.00

1.2

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

160

1.01

0.00

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.02

0.00

1.2

20.28

31.31

mg/l

—

(3045788) Cell count panel - Pleural fluid

429

2242

1.00

0.00

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

170

0.98

0.00

1.0

1.1

1.73

1.14

u/ml

0.18

120

(3023199) Leukocytes [#/volume] in Pleural fluid

556

2900

1.00

0.00

1.5

5664.96

2524.27

e6/l

0.90

409

2113

(40758358) Immune stain study

106

0.98

0.00

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

357

0.99

0.00

10.4

5.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

191

0.98

0.00

1.0

—

(3020650) Glucose [Presence] in Urine

141

733

1.00

0.00

1.5

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

163

0.99

0.00

3.8

5.5

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.02

-0.00

1.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.98

-0.00

2.7

2.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.89

-0.00

1.0

1.1

—

(3035060) Mercury [Moles/volume] in Blood

0.99

-0.00

2.0

1.5

20.04

11.47

nmol/l

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

9.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.01

-0.00

1.0

1.1

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.6

—

0.84

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SSRI – Selective serotonin reuptake inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Selective serotonin reuptake inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Selective serotonin reuptake inhibitors (SSRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints